Electronic Orders for Controlled Substances, 16902-16919 [05-6504]
Download as PDF
16902
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
DEPARTMENT OF JUSTICE
Requirements for Distributing Schedule
I and II Controlled Substances
Drug Enforcement Administration
The CSA prohibits distribution of
Schedule I and II controlled substances
except in response to a written order
from the purchaser on a form DEA
issues (21 U.S.C. 828(a)). DEA issues
Form 222 to registrants for this purpose,
preprinting on each form the registrant’s
name, registered location, DEA
registration number, schedules, and
business activity. DEA serially numbers
the forms and requires registrants to
maintain and account for all forms
issued. Executed and unexecuted Forms
222 must be available for DEA
inspection. The CSA requires that
executed Forms 222 be maintained for
two years (21 U.S.C. 828(c)).
When ordering a Schedule I or II
substance, the purchaser must provide
two copies of the Form 222 to the
supplier and retain one copy. Upon
filling the order, the supplier must
annotate both copies of the form with
details of the controlled substances
distributed, retain one copy as the
official record of the distribution, and
send the second copy of the annotated
Form 222 to DEA. Upon receipt of the
order, the purchasers must also annotate
their copy, noting the quantity of
controlled substances received and date
of receipt.
21 CFR Parts 1305 and 1311
[Docket No. DEA–217F]
RIN 1117–AA60
Electronic Orders for Controlled
Substances
Drug Enforcement
Administration (DEA), Justice.
AGENCY:
ACTION:
Final rule.
SUMMARY: DEA is revising its regulations
to provide an electronic equivalent to
the DEA official order form, which is
legally required for all distributions
involving Schedule I and II controlled
substances. These regulations will
allow, but not require, registrants to
order Schedule I and II substances
electronically and maintain the records
of these orders electronically. The
regulations will reduce paperwork and
transaction times for DEA registrants
who handle, sell, or buy these
controlled substances. This rule has no
effect on patients’ ability to receive
prescriptions for controlled substances
from practitioners, nor on their ability to
have those prescriptions filled at
pharmacies.
Effective Date: This rule is
effective on May 31, 2005. The
incorporation by reference of certain
publications listed in the rule is
approved by the Director of the Federal
Register as of May 31, 2005.
DATES:
FOR FURTHER INFORMATION CONTACT:
Patricia M. Good, Chief, Liaison and
Policy Section, Office of Diversion
Control, Drug Enforcement
Administration, Washington, DC 20537,
Telephone (202) 307–7297.
SUPPLEMENTARY INFORMATION:
I. Background
DEA’s Legal Authority for These
Regulations
DEA enforces the Controlled
Substances Act (CSA) (21 U.S.C. 801 et
seq.), as amended. DEA regulations
implementing this statute are published
in Title 21 of the Code of Federal
Regulations (CFR), Part 1300 to 1399.
These regulations are designed to
establish a framework for the legal
distribution of controlled substances to
deter their diversion to illegal purposes
and to ensure that there is a sufficient
supply of these drugs for legitimate
medical purposes.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
Regulatory History
Although the paper-based regulatory
structure limits diversion, it does not
address or provide for the use of modern
computer technologies. DEA issued
more than six million individual order
forms in fiscal year 2003. Because both
the purchaser and supplier must
maintain copies of the form for two
years, the order system requires the
maintenance of more than 24 million
forms. Many, if not most, of the
registrants using Form 222 place all
their orders for Schedules III–V
controlled substances electronically.
Many suppliers receive electronic notice
from their purchasers of their intention
to place Schedule I and II orders, but the
orders cannot be filled until the supplier
receives the DEA-issued Form 222 from
the purchaser. The processing of the
Form 222 takes one to three days from
the time the form is completed to the
time the order is delivered; electronic
orders can be processed and filled
immediately.
DEA Pilot Project
Industry asked DEA to provide an
electronic means to satisfy the legal
requirements for order forms. DEA
began discussions with the regulated
industry regarding CSOS standards in
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
1999. On January 11, 2002, DEA
published a notice in the Federal
Register expressing its intent to conduct
a pilot project to conduct performance
verification testing of public key
infrastructure enabled controlled
substances orders. This pilot project was
conducted in partnership with two
industry associations—the Health Care
Distribution Management Association
and the National Association of Chain
Drug Stores. A total of 22 DEA
registrants were listed as initial pilot
participants. Initial pilot objectives were
to ascertain the level of compatibility
and usability of CSOS standards for
electronic controlled substances
ordering applications and to test
industry’s ability to deploy these
systems. All technical test objectives
were successfully realized in early
phases of the pilot with registrants
demonstrating the ability to retrieve and
manage their CSOS digital certificates.
Where participants expressed difficulty
or reported undue burden with
processes (e.g., with initial notarization
requirements for enrollment) proposed
technical standards were reviewed and
modified, where possible, without
compromising necessary
nonrepudiation and security services
objectives.
In August 2002, pilot participants
began using CSOS certificates in
simulated environments with DEA
providing access to a test suite of CSOS
certificates. Pilot participants
demonstrated the ability to send, receive
and validate digitally signed controlled
substances orders in a test environment,
and also demonstrated the ability to
accurately reject orders, as appropriate.
Pilot outcomes allowed DEA to identify
and resolve potential challenges before
the controlled substances ordering
system was proposed. DEA continues to
provide test resources to industry
through the use of its pilot system,
allowing continued refinement of CSOS
applications.
Summary of Proposed Rule
On June 27, 2003, DEA issued a
Notice of Proposed Rulemaking (NPRM)
in which DEA proposed revisions to its
regulations to allow electronic orders if
those orders were signed using an
electronic signature that met three
criteria—authentication, nonrepudiation, and record integrity (68 FR
38558). Because only digital signatures
based on certificates issued by a
Certification Authority as part of a
public key infrastructure (PKI) meet all
three criteria, DEA proposed
requirements that apply to obtaining
and using digital certificates.
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
DEA proposed allowing regulated
entities who are eligible to order
Schedule I and II controlled substances
to issue and process electronic orders if
those orders are signed using a digital
certificate issued by a Certification
Authority run by DEA; the approach is
called the Controlled Substance
Ordering System or CSOS. Use of
electronic orders is optional; registrants
may continue to issue orders on Form
222.
DEA proposed minor organizational
revisions to the existing requirements in
Part 1305 to create subparts. Subpart A
includes those requirements that apply
to all orders. Subpart B covers the
requirements for handling Form 222
orders. Other than minor editorial
changes to make the regulations easier
to read, the existing requirements for
paper orders are unchanged. A new
subpart C was proposed to cover the
requirements for issuing and filling
electronic orders. These requirements
parallel those for Form 222 orders, but
include some differences based on the
different constraints on the two systems.
For example, the regulation specifies the
data elements required on an electronic
order; because these elements are part of
the Form 222, they are not specified for
paper orders. Orders submitted on paper
must be filled by a single registered
location because the original order form
must be maintained at the distribution
location in support of the distribution;
electronic orders may be divided and
filled from separate registered locations
owned by the same company, since the
order can be retrieved directly in
verifiable form at each distributing
location.
In addition to its revision of Part
1305, DEA proposed a new Part 1311
that includes the requirements for
obtaining, storing, using, and renewing
digital certificates. Registrants and
people granted power of attorney by
registrants to sign orders will be eligible
to obtain digital certificates. A registrant
must appoint a CSOS coordinator who
will serve as that registrant’s recognized
agent regarding issues pertaining to
issuance of, revocation of, and changes
to digital certificates issued under that
registrant’s DEA registration. These
individuals serve as knowledgeable
liaisons between one or more DEA
registered locations and the CSOS
Certification Authority (CA). The
coordinators will collect applications,
ensure that they include all of the
required information, and send them to
the CA. Part 1311 also specifies the
requirements that the digital signature
software will have to meet to ensure that
it is capable of creating and validating
digitally signed orders.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
Procedures for Obtaining a Digital
Certificate
Procedures for enrolling to obtain a
digital certificate are available on the
DEA Diversion Control Program Web
site, https://www.deadiversion.usdoj.gov,
and on the DEA E-Commerce Web site
at https://www.deaecom.gov. Applicants
can download the Diversion PKI CSOS
Enrollment document and the CSOS
Subscriber’s Manual for guidance on
enrollment procedures. DEA will begin
accepting applications to obtain digital
certificates May 31, 2005. Upon
receiving a completed application DEA
estimates that it will take the
Certification Authority 10 business days
to process the application. DEA’s
Certification Authority will maintain a
support line to assist applicants and
subscribers with issues pertaining to
certificate enrollment, issuance,
revocation, and renewal.
PKI and Digital Certificates
A public key infrastructure is
comprised of a Certification Authority,
which must verify the identity of
applicants before issuing digital
certificates, and public-private key
pairs. PKI systems are based on
asymmetric cryptography: the holder of
the digital certificate has a private key,
which only the certificate holder can
access, and a public key, which is
available to anyone. What one key
encrypts, only the other key can
decrypt. It is computationally infeasible
for the two keys to be derived from each
other. Only one public key will validate
signatures made using its corresponding
private key. Because the private key is
held by only one person, it is that
person’s responsibility to ensure that it
is not divulged or compromised.
The DEA Certification Authority (CA)
will issue digital certificates, which will
serve as an electronic equivalent of the
Form 222. DEA must serve as the CA
because a digital certificate is the
functional equivalent of a Form 222 that
the CSA requires DEA to issue. In the
same manner as DEA pre-prints the
registration information on the paper
order forms that are issued to
registrants, DEA will enter the
registration information in extensions
within the certificates that are issued to
registrants and those granted power of
attorney by registrants.
As DEA explained in the NPRM, the
process of digitally signing an order is
technically complicated (the software
uses several complex algorithms to
create an encrypted digest of the text),
but the user needs only to activate the
key and then enter one or two key
strokes to sign an order or validate it.
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
16903
Existing electronic order systems will
have to be PKI-enabled, which can be
done with commercially available
toolkits. DEA has been working with
industry to develop systems and
procedures that allow PKI-enabling
existing systems to reduce the cost of
implementation.
CSOS Certificates
All of the information currently
preprinted on the Form 222 will be part
of the extension data of the CSOS digital
certificate, which will be included with
each order that is digitally signed.
Attaching the digital certificate, with the
registration information in the extension
data, to an electronic order signed with
the digital signature is the functional
equivalent to DEA pre-printing the
registrant information on the paper
forms, thus creating an electronic
equivalent of the Form 222.
A CSOS certificate will be valid until
the DEA registration under which it is
issued expires or until the CSOS CA is
notified that the certificate should be
revoked. Certificates will be revoked if
the certificate holder is no longer
authorized to sign Schedule I and II
orders for the registrant, if the
information on which the certificate is
based changes, or if access to the private
key has been compromised or lost.
II. Discussion of Comments on the
NPRM
DEA received 11 comments on its
proposed rule. Commenters included
the major trade associations
representing pharmacies and
distributors as well as individual
companies and one vendor. This section
summarizes the comments and provides
DEA’s response.
Listed schedules. Several commenters
were concerned with proposed rule
language that implied that the digital
certificate would include extension data
that indicated the schedules the
certificate holder rather than the
registrant was authorized to order. The
commenters stated that it would be an
additional burden on suppliers if they
had to verify the eligibility of the signer,
as well as the registrant, to order
specific schedules.
DEA has revised the rule language to
clarify that only the registrant’s
authorized schedules will be included
in the extension data. If a registrant
limits an individual’s signing authority,
it is incumbent on the registrant to
ensure that the individual does not sign
orders for schedules he/she is not
authorized to order. The supplier is not
required to verify information on
schedules beyond confirming that the
E:\FR\FM\01APR2.SGM
01APR2
16904
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
registrant is authorized to order the
schedules.
Attaching the digital certificate. One
commenter expressed concern about the
statements in the preamble that a digital
certificate be attached to each order.
Because the digital certificate serves
as the equivalent of the CSA-mandated
form, the certificate, with its extension
data, must be attached to each order.
Including the certificate with each order
ensures that, just as with the paper
forms, an accurate copy of the DEA
registration information for the
customer is with the order. It should be
noted that the requirement that the
digital certificate be attached to the
order applies to when the order is
transmitted by the purchaser to the
supplier. Once orders have been
archived, each order does not have to
have the specific digital certificate
attached, as long as the certificate is
associated with the order. Thus, an
archive may have one copy of a specific
certificate that is associated with a
number of orders that have been
archived, provided that retrieval of an
order includes a copy of the certificate.
FIPS 140–1. Commenters noted that
the proposed rule referenced FIPS 140–
2, but did not mention FIPS 140–1,
causing concern that systems validated
and approved under 140–1 might not be
allowed under the new standard. They
were further concerned because the rule
did not specify the security level
required. Commenters stated that
requiring a standard beyond security
level 1 would cause difficulties for
participants.
FIPS 140–2 grandfathers FIPS 140–1;
any system validated and approved
under FIPS 140–1 is considered to be
approved and validated under FIPS
140–2. Therefore, the regulatory
provision that implementations be
certified under FIPS 140–2 incorporates,
by reference, any implementations
previously certified under FIPS 140–1.
With respect to the security level
required, DEA agrees with comments
that Security Level 1 is appropriate and
has included it in the final rule.
Commenters objected to the
requirement that the private keys be
stored on a FIPS-approved module. As
DEA explained in the NPRM,
government agencies must adopt FIPS
requirements for any federal system,
such as CSOS. DEA, therefore, must
require that storage of keys be on FIPSapproved systems. While DEA
encourages the use of smartcards,
biometrics, or other secure hardware
devices for private key storage within
the CSOS architecture, use of such
devices is voluntary. The regulations
only require that the private key be
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
stored on a FIPS-approved
cryptographic module.
Power of Attorney. A number of
commenters raised issues related to the
power of attorney (POA) provisions.
Several suggested that the existing
requirement that the POA letter be
signed by the person who signed the
most recent registration application is
impractical for companies that have
national or regional distribution
operations. Other commenters suggested
that the application for a digital
certificate, handled through the CSOS
coordinator, could replace the POA
letter and process.
The intent of this rulemaking is to
establish an electronic means of
satisfying the order form requirements—
not to change the existing order form
requirements. DEA did not propose to
change the POA requirement or process,
which was established to ensure that all
activities by a registrant with respect to
order forms be under the ultimate
control of one responsible individual
within the registrant. Any concerns
regarding existing requirements with
respect to POA will have to be
considered in a separate action; they are
beyond the scope of this CSOS
rulemaking.
With respect to the suggestion that
application for a digital certificate serve
as a substitute for granting power of
attorney, DEA wishes to note that the
granting of power of attorney is an
explicit legal act of assignment of
authority from an authorized individual
to another; accepting the application for
a digital certificate as a substitution
would make the assignment implicit,
which would not be acceptable to DEA.
Any assignment of the authority to
obtain and execute order forms on
behalf of a registrant must be an explicit
legal act.
One commenter noted that the
language in § 1305.12(d) that states that
orders must be signed by a person
authorized to sign an application for
registration was wrong and should state
that orders must be signed either by a
person who is authorized to sign a
registration application or a person
granted POA to sign orders. DEA agrees
and has changed the rule.
Tracking number. Several
commenters stated that the format of the
unique tracking number that a registrant
assigns to an order was incorrect, that
the last two digits of the year should
come first. DEA agrees and has
corrected the rule.
Order contents. Commenters
suggested several changes to the
requirements for order contents. DEA
agrees that the complete address of the
supplier could be provided by either the
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
purchaser or the supplier and has
changed the rule. Similarly, DEA agrees
that the order could include either the
National Drug Code (NDC) number or
the drug name. DEA emphasizes that the
system used to view the orders must
provide the drug description if the NDC
code is used in the order.
Linked records. Commenters objected
to the use of the phrase ‘‘electronically
linked’’ records because they think that
links could be electronic or manual. In
technical discussions with DEA,
industry clarified that their concern was
that DEA might interpret ‘‘electronically
linked’’ to require active rather than
passive links, where all order data are
linked automatically. Passive links
would allow the data to be stored in
separate databases linked by one or
more data elements common to all
records.
DEA emphasizes that it is not
requiring any specific type of link;
DEA’s only concern is that if it requests
copies of orders (e.g., for a particular
customer or substance), the registrant
must be able to produce the requested
records (i.e., both the electronic orders
and the linked distribution records)
upon request in a format that an agent
can read and understand. DEA has
revised the rule to clarify that ‘‘readable
format’’ means that a person, not a
computer, can easily read the
documents.
Corrections. Several commenters
identified changes needed to correct
regulatory language. In § 1305.22(c)(1),
DEA proposed that suppliers should
verify the signature and order by
‘‘having’’ software that complies with
Part 1311. The commenter
recommended ‘‘using’’ instead of
‘‘having.’’ DEA agrees and has made the
change.
Commenters stated that the proposed
language in § 1305.25(b) and (c) that
requires the supplier to provide a reason
for not filling the order was inconsistent
with the existing rule. DEA agrees and
has changed the language to clarify that
a supplier must notify a purchaser that
an order will not be filled, however, the
supplier does not need to provide a
reason for refusing to fill an order.
Commenters asked DEA to make the
definition of digital certificate specific
to CSOS. DEA disagrees. The definition
is intended to be general and will cover
more than CSOS certificates. In the
regulatory text, however, DEA has
added ‘‘CSOS’’ before digital certificate
wherever the certificate is limited to the
CSOS certificate.
One commenter asked whether ‘‘a
registrant’s recognized agent’’ was
different from a CSOS coordinator. The
two are the same; DEA has revised the
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
rule to replace registrant’s recognized
agent with CSOS coordinator.
Central Ordering. A commenter asked
whether the § 1305.22(f) requirement to
ship to the registered location of the
purchaser allowed for shipment to a
different registered location if the order
was issued by a central ordering facility.
A number of firms issue orders for all
their registered locations from a central
location which may not, itself, be
registered. Each order, however, can be
for only one specific registered location
and the supplier must ship to that
location. If the registered location
identified within the order deviates
from that identified within the digital
certificate, the supplier cannot fill the
order; a new order must be requested
from the purchaser.
Commenters also recommended that
for central processing of orders that DEA
allow either the central location or the
location filling part of the order to create
the record. DEA agrees that either
location may create the record and has
revised the rule. DEA’s concern is not
with the creation of the record, but with
its maintenance. The registrant that
distributes a controlled substance must
maintain a full record of the order and
make it available for DEA on request.
One commenter raised the issue of
linking a single certificate to multiple
locations. As DEA explained in the
NPRM, DEA understands the concern
and has taken steps to reduce the
burden for individuals who hold keys
for many locations, but to serve as an
equivalent of a Form 222, each digital
certificate must be specific to a single
registered location.
Endorsed, lost, and canceled orders.
Commenters questioned whether the
proposed rule for endorsing electronic
orders could be implemented, noting
that the requirements were confusing
and cumbersome. DEA has reviewed
this issue and agrees with the
commenters that endorsing electronic
orders in a manner that provides
adequate safeguards may be technically
too complicated. Consequently, DEA
has decided to not allow endorsement of
electronic orders. Because orders are
rarely endorsed and the almost
instantaneous communication of
electronic orders and confirmations
mean that a purchaser will learn that the
supplier cannot fill all or part of an
order shortly after the order is
submitted, DEA does not expect this to
pose any significant problem for
registrants. The purchaser can quickly
issue a new electronic order to another
supplier for any items the first supplier
cannot fill. Finally, if the order is
originally submitted to a firm that
processes orders centrally, the central
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
processing supplier can fill the order
from multiple locations without
endorsement.
Commenters also stated that the
meaning of § 1305.26 on lost orders was
confusing and requested that only the
purchaser maintain records of lost
orders. DEA agrees and has revised the
rule to specify that a supplier need
maintain only those orders that the
supplier fills.
Commenters stated that suppliers
should not be required to maintain
records of orders that are canceled. DEA
agrees. Suppliers are only required to
maintain records of orders that they fill.
Suppliers need not return the electronic
order to the purchaser, however, the
supplier must notify the purchaser of
the cancellation of the order.
Commenters also said that purchasers
should be able to use any method to
notify the supplier that an order was
canceled. DEA disagrees. Notification of
an order cancellation must be written so
that the purchaser can maintain a
verifiable record. Written notification
includes paper, facsimile, or
electronically transmitted notifications
such as e-mail; notification by telephone
is not allowed.
Validity of a signature. Commenters
asked whether it was feasible to
determine whether a signature was valid
at the time of signing. Commenters were
particularly concerned that, if there was
a delay in processing an order, they
should be able to reject an order if the
signature was no longer valid at the time
of shipping.
The purpose of the requirement for
consistent time systems is to allow
suppliers to determine whether a
signature was valid at the time of
signing. If a digital signature was valid
on Friday when the order was signed,
but expired on Monday, DEA considers
that the order is valid. Unless DEA or
the purchaser has notified a supplier
that orders issued by a specific person
should not be filled, an order signed
with a digital certificate that was valid
at the time of signing is a valid order.
A registrant may choose not to fill the
order for any reason; if registrants want
to require that the signature still be
valid at the time of filling, they may do
so. Suppliers have the option of
imposing more stringent standards. As a
secondary note, DEA wishes to stress
that once a supplier has validated a
signature on an order, it is not necessary
to re-validate the signature prior to
actually shipping the order to the
purchaser.
Time period for reporting key
compromise or loss of privilege.
Commenters objected to the requirement
that they report loss, theft, or
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
16905
compromise of the key within 24 hours
of such loss, theft, or compromise, and
that they report a certificate holder’s
loss of signing privilege within six
hours. They also stated that they wanted
to be able to report loss of signing
privilege in advance (e.g., when they
learn an employee will be leaving the
firm on a certain date). They stated that
the 24-hour and 6-hour time frames
were unrealistic and could result in
notifications filed outside of business
hours.
Registrants may notify the CA in
advance of revocations. DEA agrees that
the 24-hour period should be within 24
hours of substantiation of key
compromise, etc., and has changed the
rule. On the 6-hour notification, DEA
disagrees with the commenters. DEA
believes it is important that the CA be
notified as soon as someone’s signing
privileges are revoked. The digital
certificate is the equivalent of a Form
222—a former employee still in
possession of their digital certificate and
keys would have all they needed to
generate orders that would be otherwise
indistinguishable from legitimate
orders. In the paper world, this concern
does not exist since a former employee
would no longer have access to the
order forms and, thus, could not engage
in any mischief. DEA notes that the CA
will be staffed 24/7 so there is no need
to wait until the next business day. An
e-mail to the CA that is digitally signed
by the coordinator or registrant will be
sufficient notification.
Certification Authority. Commenters
raised concerns about the DEA CA being
run by a contractor and asked about the
safety of information. DEA emphasizes
that although a contractor may be used
to carry out the day-to-day operations of
the CA, the contractor will operate
under direct DEA supervision and
control. All Federal contractors are
subject to the same legal requirements
as government employees in regard to
protection of information. DEA may use
information submitted in its
investigations, but the information
would not be released for other
purposes.
Reports to DEA. Commenters objected
to the requirement that suppliers file
reports on orders with DEA every other
business day. They stated that this
frequency of filing would not provide
them with an opportunity to review and
correct minor discrepancies. With paper
orders, DEA knows which registrants
have executed Form 222, which
provides a control on the system. DEA
needs frequent reports on electronic
orders because it has no other means of
determining who is ordering and in
what volume. DEA recognizes that some
E:\FR\FM\01APR2.SGM
01APR2
16906
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
of the data may be imprecise due to
changes in orders, but DEA needs
frequent submissions of reports to
account for all orders generated by a
given purchasing registrant and as a
means to identify and account for all
outstanding orders for a given registrant.
Commenters also recommended
changes to the information provided in
the daily reports to make the data
elements consistent with ARCOS data
elements and to add four elements on
the substances ordered. DEA agrees with
the commenters. DEA will specify a
format for the report that is consistent
with the ARCOS reports plus the data
fields on what was ordered. DEA notes
that ARCOS is preparing to allow
electronic filing of reports; when this
occurs, DEA plans to develop a process
by which the summary reports can be
accepted as a substitute for ARCOS
reporting for Schedule I and II
substances, with the usual ARCOS
provisions for filing corrections.
Adoption of new technologies.
Commenters stated that it was unclear
how DEA would evaluate new
technologies and recommended that
DEA develop a rapid means for
evaluating and approving new
technologies. DEA understands the
commenters’ concern, but approval of
any new technology would be subject to
the Administrative Procedure Act
requirements for public notice and
comment prior to adoption. Beyond the
statutory mandates, DEA thinks it is
vital that the regulated community have
an opportunity to consider and discuss
new methods to ensure that any new
rules can be accommodated by existing
systems. Although the development of
this rule took several years, DEA
believes that the time was well spent
because discussions that DEA and
industry held made it possible for all
parties to identify potential problems
and find solutions prior to publishing a
regulation. DEA does not anticipate that
review and recognition of suitable
alternative technologies should take that
long.
Audits. Comments expressed concern
about the scope of the third-party audits
and DEA audits. They specifically stated
that the reports to DEA should not be
included in the third-party audits.
DEA agrees with the commenters that
the reports to DEA would not be part of
third-party audits. The independent
third-party audit is intended to ensure
that the digital signature system
functions properly for both the supplier
and purchaser.
Reverse Distributors. Several
commenters asked how the electronic
order system will work for reverse
distributors. DEA recognizes that the
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
ordering system has different
characteristics in reverse distribution
and intends to address issues related to
those distributions in a separate
rulemaking.
Other Issues. Commenters objected to
the mention of biometrics and smart
cards. DEA notes that certificate holders
may want to consider using biometric
passwords or smart cards, but DEA is
not requiring them to do so. Keys may
be stored on any secure system provided
that the storage module is approved
under FIPS 140–2.
Commenters questioned the use of
‘‘system.’’ DEA agrees with commenters
that systems for creating and processing
digitally signed orders may be one or
more software systems. As noted above,
DEA’s concern is the integrity and
availability of the records of orders, not
the technologies and software used to
create and store the information.
Commenters asked that DEA include
a definition or description of the
subscriber agreement. DEA does not
believe that it is necessary to define the
subscriber agreement. The DEA CA will
provide the agreement, appropriately
titled, to each certificate holder.
Commenters objected to the statement
in the NPRM that the practical
implementation of PKI systems is
simple. DEA understands and explained
in the NPRM that the technologies
involved in PKI systems are complex,
but from the user’s standpoint, digital
signatures are simple because so much
of the work is actually done by machine.
After authenticating themselves to the
system and activating the key, the signer
generally digitally ‘‘signs’’ the document
with a single key stroke.
One commenter raised issues related
to digital certificates for pharmacists for
use in the electronic prescription
system. This issue is beyond the scope
of this notice; DEA will address the
issue when it proposes its rule for
electronic prescriptions.
A commenter noted that the five-year
transition period used in the economic
analysis may be optimistic. DEA
recognizes that the electronic orders
may phase in at a different rate; some
registrants may continue to use Forms
222 indefinitely, as the rule allows. The
five-year period was simply used to
estimate costs to avoid understating
those costs.
One commenter supported the
proposed rule, but expressed the hope
that pharmacies would not bear the cost
of implementation. DEA notes that use
of electronic orders is voluntary. DEA
believes that the system will provide
cost savings to both purchasers and
suppliers, but no registrant is required
to adopt electronic orders.
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
One vendor recommended that DEA
adopt an approach more consistent with
the vendor’s technology. DEA is not
dictating a particular technology or PKI
implementation. Any approved system
that meets the criteria for
authentication, non-repudiation, and
record integrity may be used.
Special Note Regarding Certificate
Extension Data
Finally, following publication of the
proposed rule, DEA modified the
specification for the certificate
extensions. Certain registrants had
expressed concerns regarding using the
certificates for other health care
purposes because their DEA registration
number appeared in plain text in the
certificate, thus making it easily
accessible to the recipient. To address
this concern, DEA has modified the
certificate profile to allow that, in lieu
of listing the plain text DEA number, the
DEA number extension will contain a
hash value generated from the DEA
number and the specific certificate
subject distinguished name serial
number using the SHA–1 hashing
algorithm. Because the DEA number
will no longer be available in plain text
in the certificate, DEA is modifying the
order format requirement in Section
1305.21 to require that the purchaser
include their DEA registration number
in the body of the order. Further,
Section 1311.55 is being amended to
require that a supplier must verify that
the DEA number listed in the body of
the order is the same as the DEA
number associated with the certificate.
The verification is necessary to avoid
circumstances where a person who has
been granted POA for multiple
registered locations does not
inadvertently sign an order with the
wrong certificate/private key.
III. Discussion of the Final Rule
Except for the changes discussed
above, DEA is adopting the rule as
proposed. Part 1305 has been
reorganized to place requirements that
apply to all Schedule I and II orders in
subpart A; these include old §§ 1305.01,
1305.02, 1305.03, 1305.04, which retain
their numbers, old § 1305.07 (power of
attorney), which is redesignated as
§ 1305.05, old § 1305.08 (persons
entitled to fill orders), which is
redesignated as § 1305.06, and old
§ 1305.16 (special procedures for filling
certain orders), which is redesignated as
§ 1305.07. The remainder of old Part
1305 is subpart B, which covers the
requirements for obtaining, executing,
and filling orders on Form 222. Subpart
B includes old §§ 1305.05 and 1305.06
(procedures for obtaining and executing
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
Forms 222), which are redesignated as
§§ 1305.11 and 1305.12, and old
§§ 1305.09–1305.15, which are
redesignated as §§ 1305.13–1305.19.
These sections include specific
references to orders on Form 222.
Subpart C covers the requirements for
electronic orders.
Section 1305.21 specifies that an
electronic order must be signed with a
CSOS digital certificate and that the
order may include substances other than
Schedule I and II controlled substances.
The section specifies the data fields that
must be included in electronic orders.
Section 1305.22 specifies procedures
for filling electronic orders.
Section 1305.23 covers endorsing
electronic orders. As discussed above,
endorsement of electronic orders will
not be allowed.
Section 1305.24 covers central
processing of orders. These
requirements are also different for
electronic orders because with
electronic orders, the supplier may have
multiple registered locations fill parts of
an order provided that the supplying
company owns and operates all of the
locations filling an order.
Sections 1305.25 and 1305.26 specify
the requirements for handling
unaccepted and defective electronic
orders and lost orders.
Section 1305.27 covers preservation
of electronic orders.
Section 1305.28 covers canceling and
voiding electronic orders.
Section 1305.29 specifies the
requirements for reporting electronic
orders to DEA. Suppliers may submit
either a copy of the order and its linked
records or a report in a format DEA
specifies. DEA intends that the report
will be identical to the ARCOS report in
format with four additional data
elements: the NDC number, quantity,
unit, and strength ordered.
New Part 1311 covers the
requirements for digital certificates.
Subpart A includes the scope,
definitions, standards for electronic
orders, and incorporations by reference.
Subpart B covers the requirements for
obtaining and using CSOS digital
certificates.
Section 1311.10 specifies who is
eligible to obtain a CSOS certificate;
§ 1311.15 covers the limitation of
certificates to the schedules authorized
16907
for the DEA registration under which
the certificate is issued. The revised
section states that the registrant is
responsible for ensuring that any person
whose signing authority the registrant
limits abides by those limits.
Section 1311.20 specifies the
requirements for CSOS coordinators.
Section 1311.25 specifies the
requirements for obtaining a CSOS
certificate.
Section 1311.30 provides the
requirements for using and storing a
digital certificate.
Section 1311.35 specifies the number
of certificates needed.
Section 1311.40 specifies when a new
certificate must be obtained.
Section 1311.45 specifies
requirements for registrants that grant
power of attorney authority.
Section 1311.50 specifies
requirements for recipients handling
electronic orders prior to filling them.
Section 1311.55 specifies software
requirements for handling electronic
orders.
Section 1311.60 specifies
recordkeeping requirements.
PART 1305.—DISTRIBUTION TABLE
Old section
New section
1305.01—Scope of part 1305 ..................................................................
1305.02—Definitions ................................................................................
1305.03—Distributions requiring order forms ..........................................
1305.04—Persons entitled to obtain and execute order forms ...............
1305.05—Procedure for obtaining order forms ........................................
1305.06—Procedure for executing order forms .......................................
1305.07—Power of attorney .....................................................................
1305.08—Persons entitled to fill order forms ...........................................
1305.09—Procedure for filling order forms ..............................................
1305.10—Procedure for endorsing order forms ......................................
1305.11—Unaccepted and defective order forms ...................................
1305.12—Lost and stolen order forms .....................................................
1305.13—Preservation of order forms .....................................................
1305.14—Return of unused order forms .................................................
1305.15—Cancellation and voiding of order forms ..................................
1305.16—Special procedure for filling certain order forms .....................
1305.01—Scope of part 1305.
1305.02—Definitions.
1305.03—Distributions requiring order forms.
1305.04—Persons entitled to obtain and execute order forms.
1305.11—Procedure for obtaining DEA Forms 222.
1305.12—Procedure for executing DEA Forms 222.
1305.05—Power of attorney.
1305.06—Persons entitled to fill DEA Forms 222.
1305.13—Procedure for filling DEA Forms 222.
1305.14—Procedure for endorsing DEA Forms 222.
1305.15—Unaccepted and defective DEA Forms 222.
1305.16—Lost and stolen DEA Forms 222.
1305.17—Preservation of DEA Forms 222.
1305.18—Return of unused DEA Forms 222.
1305.19—Cancellation and voiding of DEA Forms 222.
1305.07—Special procedure for filling certain DEA Forms 222.
Incorporation by Reference
V. Required Analyses
The following standards are
incorporated by reference:
• FIPS 140–2, Security Requirements
for Cryptographic Modules.
• FIPS 180–2, Secure Hash Standard.
• FIPS 186–2, Digital Signature
Standard.
These standards are available from the
National Institute of Standards and
Technology, Computer Security
Division, Information Technology
Laboratory, National Institute of
Standards and Technology, 100 Bureau
Drive, Gaithersburg, MD 20899–8930
and are available at https://csrc.nist.gov/.
Executive Order 12866
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
This regulation has been drafted and
reviewed in accordance with Executive
Order 12866, ‘‘Regulatory Planning and
Review’’, Section 1(b), Principles of
Regulation. It has been determined that
this is a ‘‘significant regulatory action’’
under Executive Order 12866, Section
3(f), Regulatory Planning and Review,
and accordingly this rule has been
reviewed by the Office of Management
and Budget.
DEA has conducted a cost-benefit
analysis of the rule, which the Office of
Management and Budget has reviewed.
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
The Economic Impact Analysis for the
proposed rule was posted on the
Diversion Control Program Web site.
That analysis has been updated to
account for the number of orders
expected in 2004 (6,561,000), the first
year of implementation, and to adjust
registrant estimates based on data from
DEA’s ARCOS reporting system. DEA
estimates that about 98,000 registrants
order Schedule I and II controlled
substances and will apply for about
145,000 digital certificates. Over ten
years, DEA estimates that electronic
orders will reduce the annualized cost
of Schedule I and II orders by $284
million; the annualized costs of digital
E:\FR\FM\01APR2.SGM
01APR2
16908
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
certificates are estimated to be $20
million. The annualized net benefit of
the rule, therefore, is $264 million.
As discussed in the NPRM, DEA
developed estimates of the time
required for each step in the process of
issuing and processing an order and
used weighted wage rates based on the
number of orders registrant groups are
estimated to issue. DEA estimates that
issuing and processing a Form 222 order
costs purchasers about $26 and
suppliers about $13. In contrast, issuing
and processing a digitally signed order
will cost about $2.60 for purchasers and
$3.00 for suppliers. (These costs do not
include the cost of obtaining a digital
certificate or installing software, most of
which are one-time costs.) The costs for
a single registrant vary depending on
the number of orders issued and filled.
DEA estimates that annual costs for
Form 222 orders range from $26 for a
registrant who issues a single order to
more than $184,000 for distributors who
both issue and fill orders. The annual
costs for electronic orders range from
$2.60 to about $40,000. The initial
registrant costs of obtaining a digital
certificate range from $156 to about
$600, varying with the number of
applicants a registrant has.
Table 1 presents the total annual
hours and costs for the Form 222 system
for 2004 orders. Tables 2–4 present the
total annual hours and costs for
obtaining digital certificates, issuing
electronic orders, and developing and
installing software, if these activities
occurred in a single year.
TABLE 1.—TOTAL ANNUAL HOURS AND COSTS FOR THE FORM 222 SYSTEM
[2004 orders]
Hours
Labor
Capital
O&M
Total
Purchaser:
Complete and send order .............................................
Requisition order ...........................................................
Annotate order ..............................................................
File orders .....................................................................
Supplier:
Enter order ....................................................................
Annotate order ..............................................................
Compile and send to DEA ............................................
File orders .....................................................................
1,640,250
3,124
328,050
109,350
$139,323,000
265,000
27,865,000
3,087,000
........................
........................
........................
$129,700
$7,355,000
23,000
........................
2,668,000
$146,677,000
288,000
27,865,000
4,472,000
1,640,250
328,050
90,936
109,350
58,770,000
21,212,000
3,258,000
3,918,000
........................
........................
........................
129,700
........................
........................
174,000
2,668,000
58,770,000
21,212,000
3,433,000
5,303,000
Total ...................................................................
4,249,360
257,698,000
259,000
12,887,000
270,844,000
TABLE 2.—TOTAL HOURS AND COSTS FOR DIGITAL CERTIFICATES
Hours
Purchaser:
Complete application ................................................................................
Complete application—coordinator ...........................................................
Generate keys ..........................................................................................
Learn to use signature .............................................................................
Renewal—one year ..................................................................................
Renewal—3 year-annual ..........................................................................
Supplier:
Complete application ................................................................................
Complete application—coordinator ...........................................................
Generate keys ..........................................................................................
Learn to use signature .............................................................................
Renewal ....................................................................................................
Total ...................................................................................................
Labor
O&M
Total
58,950
78,755
12,116
20,778
1,234
3,627
$5,007,000
6,689,000
1,029,000
1,765,000
105,000
308,000
........................
$638,000
........................
........................
........................
........................
$5,007,000
7,328,000
1,029,000
1,765,000
105,000
308,000
3,311
345
406
2,032
406
214,000
22,000
26,000
131,000
26,000
........................
2,790
........................
........................
........................
214,000
25,000
26,000
131,000
26,000
181,960
15,324,000
641,000
15,965,000
TABLE 3.—TOTAL HOURS AND COSTS FOR ELECTRONIC ORDERS
Hours
Purchaser:
Sign orders ...........................................................................................................................
Edit and archive ....................................................................................................................
Supplier:
Validate orders .....................................................................................................................
Collect and send to DEA ......................................................................................................
Edit and archive ....................................................................................................................
Total ...............................................................................................................................
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
E:\FR\FM\01APR2.SGM
Activities
Total cost
36,450
164,025
6,561,000
6,561,000
$3,096,000
13,932,000
27,338
5,473
273,375
6,561,000
109,460
6,561,000
1,768,000
354,000
17,676,000
506,661
........................
36,826,000
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
16909
TABLE 4.—TOTAL HOURS AND COSTS FOR THE ELECTRONIC ORDER SOFTWARE
Hours
Purchaser:
Install—chains ..........................................................................................
Install software—other ..............................................................................
Install—practitioner ...................................................................................
Supplier:
Install software ..........................................................................................
Software Developer:
Development .............................................................................................
Maintenance .............................................................................................
Upgrades ..................................................................................................
Audit ..........................................................................................................
Total ...................................................................................................
To estimate costs over the first ten
years, DEA assumed that
implementation would be phased in
over the first five years (i.e., it would be
five years before all registrants were
using the electronic order system).
Based on discussions with industry, the
phase-in was estimated to occur at 20
percent in the first year, 40 percent in
the second, 20 percent in the third, and
10 percent each in the fourth and fifth
years. DEA made the conservative
estimate that orders would phase in at
Labor
O&M
Total
8,680
314,408
43,940
$666,000
13,010,000
1,818,000
........................
........................
........................
$666,000
13,010,000
1,818,000
280
11,600
........................
11,600
103,600
89,000
17,800
2,314
9,700,000
3,683,000
1,367,000
96,000
........................
........................
........................
$593,000
9,700,000
3,683,000
1,367,000
689,000
580,022
30,352,000
593,000
30,945,000
the same rate as digital certificates.
Because a few distributors and large
chain drug stores supply and order a
large proportion of the drugs, it is likely
that orders will phase in more quickly
than digital certificates will. A faster
phase-in will increase the net benefits;
a slower rate would lower the benefits.
DEA also assumed that the number of
orders would increase seven percent
annually. The seven percent increase is
based on the average annual increase in
orders over the last seven years. The
total cost of both systems was estimated
using a seven percent and a three
percent discount rate. Table 5 presents
the ten-year total cost of orders under
the Form 222 system, the electronic
system, and the combined systems as
the electronic system is phased in over
the first five years as well as the
annualized cost of the three systems
over ten years. Table 6 presents the
costs of digital certificates and software
needed to create digitally signed orders.
TABLE 5.—TOTAL COST OF ORDERS OVER TEN YEARS
[Present value]
Paper system
Total (7%) ..................................................................................................................
Annualized (7%) ........................................................................................................
Total (3%) ..................................................................................................................
Annualized (3%) ........................................................................................................
$2,699,913,000
384,407,000
3,223,440,000
377,886,000
TABLE 6.—TOTAL COSTS OF DIGITAL Forms 222 must be completed because
CERTIFICATES AND SOFTWARE OVER the form is limited to ten items. With
the electronic orders, they will be able
10 YEARS
to submit a single order covering all
controlled substance and other
prescription drugs being purchased
New costs
from the supplier. The combined orders
Total (7%) .............................
$149,308,000 should reduce the orders that need to be
Annualized (7%) ...................
21,258,000 logged, tracked, and handled by both
Total (3%) .............................
172,093,000 purchasers and suppliers.
Annualized (3%) ...................
20,275,000
Electronic orders should also bring
faster receipt of controlled substances.
In addition to the cost savings,
Under the present system, the purchaser
electronic orders will also provide a
has the choice of sending the order by
number of other benefits that cannot be
overnight service at considerable cost,
quantified. Purchasers will be able to
mailing it and waiting several days, or
create and send single unified
sending the order back with the delivery
controlled substance orders to their
truck, which may not be returning
suppliers. With Forms 222, purchasers
directly to the distributor. In most cases,
must create the separate Form 222 for
the purchaser is likely to have to wait
the Schedule I and II controlled
at least two days and possibly four or
substances and complete other orders
five days when the order is mailed or is
for all other controlled substance
shipped back by truck. If the distributor
purchases from a particular supplier. If
that receives the order cannot fill it, the
a purchaser needs more than 10
distributor may endorse it to another
Schedule I or II substances, multiple
distributor and ship it on to another
[Present value]
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
Electronic system
$298,086,000
42,441,000
363,653,000
42,631,000
Combined
phase-in
$704,112,000
100,250,000
781,438,000
91,608,000
distribution point, further delaying the
final shipment. Electronic orders will be
received almost instantly and can be
shipped the same day. This speed may
allow purchasers to order only when
they need an item and limit the quantity
of controlled substances that they stock.
Limiting the quantity of Schedule I and
II controlled substances in stock reduces
the possibility of diversion and the cost
of security.
With the Form 222, if a supplier
cannot fill all of an order, the supplier
may endorse the entire order over to
another supplier. The order cannot be
divided and filled in part by one
supplier and in part by a second, even
if both suppliers belong to the same
company. Because each location holds a
separate registration, a distributor with
multiple locations must maintain stocks
of all Schedule I and II controlled
substances at each location to be able to
fill orders for these substances from that
location. Some distributors have created
centralized systems where all orders are
E:\FR\FM\01APR2.SGM
01APR2
16910
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
processed through the central
distribution office, which then transmits
parts of the orders to the warehouses
that hold specific items. The Form 222
system cannot take advantage of this
arrangement because the paper must
accompany the order. With electronic
orders, DEA will allow a distributor
with a central distribution system to
divide an order and ship parts of the
order from different distribution points.
New orders will not need to be
generated because the central computer
system can track each item in the order
and ensure that it is shipped to the
appropriate registrant only once. DEA
and the supplier will have the records
necessary to maintain the closed system
of control while allowing the supplier to
take advantage of its own system of
distribution.
A copy of the Economic Impact
Analysis of the Electronic Orders Rule
is available on the Diversion Control
Program’s Web site.
Regulatory Flexibility Act
The Regulatory Flexibility Act (5
U.S.C. 601–612) requires Federal
agencies to determine whether
regulations have a significant economic
impact on a substantial number of small
entities or have a disproportionate effect
on small entities. DEA, as part of its
economic analysis, considered the costs
of the existing system and the electronic
system on small entities. The
annualized costs of the Form 222 system
for the smallest entities (Narcotic
Treatment Programs with less than
$100,000 in revenues), are 1.66 percent
of annual revenues; for these registrants,
the annual costs of the electronic orders
are about 0.24 percent of annual
revenues. For most small entities
affected by the rule, the cost of the
electronic system will be less than 0.1
percent of revenues or sales.
Consequently, the Deputy Administrator
hereby certifies that this rulemaking has
been drafted in accordance with the
Regulatory Flexibility Act (5 U.S.C.
605(b)), has reviewed this regulation,
and by approving it certifies that this
regulation will not have a significant
economic impact on a substantial
number of small entities.
A copy of the small business analysis
for this proposed rule, which is section
7 of the economic analysis, can be
obtained from the Diversion Control
Program web site or by contacting the
Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement
Administration, Washington, DC 20537,
Telephone (202) 307–7297.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
Small Business Regulatory Enforcement
Fairness Act of 1996
This rule has been determined to be
a major rule as defined by Section 804
of the Small Business Regulatory
Enforcement Fairness Act of 1996. This
rule will result in an annual effect on
the economy of $100,000,000 or more,
but will not impose a major increase in
costs or prices; or significant adverse
effects on competition, employment,
investment, productivity, innovation, or
on the ability of United States-based
companies to compete with foreignbased companies in domestic and
export markets. In fact, this rule will
result in a significant reduction in the
cost of ordering Schedule I and II
controlled substances.
Paperwork Reduction Act
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA)
submitted the following information
collection requests to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
Under the Paperwork Reduction Act,
DEA is required to estimate the burden
hours and other costs of any
requirement for recordkeeping and
reporting over a three-year period.
Therefore, DEA proposed the revision of
an existing collection of information
U.S. Official Order Forms for Schedules
I and II Controlled Substances
(Accountable Forms), Order Form
Requisition, (OMB Control # 1117–
0010), and the creation of a new
collection of information Reporting and
Recordkeeping for Digital Certificates
under the Paperwork Reduction Act of
1995. This process is conducted in
accordance with 5 CFR 1320.11. The
Information Collection Request was
submitted to the Office of Management
and Budget for review under section 307
of the Paperwork Reduction Act.
Overview of U.S. Official Order Forms
for Schedules I and II Controlled
Substances (Accountable Forms), Order
Form Requisition Information
Collection
(1) Type of information collection:
Revision of existing collection.
(2) The title of the form/collection:
U.S. Official Order Forms for Schedule
I and II Controlled Substances
(Accountable Forms), Order Form
Requisition.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form No.: DEA Form 222, U.S.
Official Order Forms for Schedule I and
II Controlled Substances (Accountable
Forms)
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
DEA Form 222a: Order Form
Requisition
Applicable component of the
Department sponsoring the collection:
Office of Diversion Control, Drug
Enforcement Administration, U.S.
Department of Justice
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Non-profit, state and local
governments.
Abstract: DEA–222 is used to transfer
or purchase Schedule I and II controlled
substances and data are needed to
provide an audit of transfer and
purchase. DEA–222a Requisition Form
is used to obtain the DEA–222 Order
Form. Persons may also digitally sign
and transmit orders for controlled
substances electronically, using a digital
certificate. Orders for Schedule I and II
controlled substances are archived and
transmitted to DEA; both the supplier
and purchaser must retain records for
two years.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: DEA estimates that the
rule will affect 98,000 registrants. The
average time for requisitioning Form
222 is 0.05 hours. The average time for
completing, annotating and filing paper
orders for purchasers is 0.317 hours. It
is estimated that suppliers spend, on
average, 0.317 hours annotating,
entering and filing the DEA Forms 222.
Suppliers spend, on average, 9 hours a
month logging and tracking order forms
and preparing the mailing to DEA. The
average time for signing and annotating
electronic orders is estimated to be
0.031 hours per order for purchasers;
the average time for validating and
annotating electronic orders is estimated
to be 0.046 hours per order for
suppliers, who also spend 0.05 hours
every other business day sending
reports to DEA.
(6) An estimate of the total public
burden (in hours) associated with the
collection: As registrants adopt the
electronic ordering, the annual burden
hours would average 2.5 million hours
a year. During this period, DEA assumes
that 20 percent of orders would be
electronic in year 1, 60 percent in year
2, and 80 percent in year 3, with a 7
percent growth rate for orders per year.
Overview of Reporting and
Recordkeeping for Digital Certificates
Information Collection
(1) Type of information collection:
New collection.
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
(2) The title of the form/collection:
Reporting and Recordkeeping for Digital
Certificates.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form No.:
DEA Form 251: CSOS DEA Registrant
Certificate Application.
DEA Form 252: CSOS Principal
Coordinator/Alternate Coordinator
Certificate Application.
DEA Form 253: CSOS Power of
Attorney Certificate Application.
DEA Form 254: CSOS Certificate
Application Registrant List Addendum.
CSOS Certificate Revocation.
Applicable component of the
Department sponsoring the collection:
Office of Diversion Control, Drug
Enforcement Administration, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Non-profit, state and local
governments.
Abstract: Persons use these forms to
apply for DEA-issued digital certificates
to order Schedule I and II controlled
substances. Certificates must be
renewed upon renewal of the DEA
registration to which the certificate is
linked. Certificates may be revoked and/
or replaced when information on which
the certificate is based changes.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: DEA estimates that the
rule will affect 98,000 registrants and
145,000 certificate holders. The average
time for completing the application for
a digital certificate to order controlled
substances is estimated to be from 0.72
hours to 1.24 hours. Certificate renewal
is estimated to take 0.083 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: As registrants adopt the
electronic ordering, the annual burden
hours would average 48,500 hours a
year. During this period, DEA assumes
that 80 percent of the certificate holders
will apply for certificates.
If additional information is required
regarding these collections of
information, contact: Brenda E. Dyer,
Department Clearance Officer,
Information Management and Security
Staff, Justice Management Division,
United States Department of Justice,
Patrick Henry Building, Suite 1600, 601
D Street, NW., Washington, DC 20530.
Executive Order 12988
This regulation meets the applicable
standards set forth in Sections 3(a) and
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
3(b)(2) of Executive Order 12988 Civil
Justice Reform.
Executive Order 13132
This rulemaking does not preempt or
modify any provision of state law; nor
does it impose enforcement
responsibilities on any state; nor does it
diminish the power of any state to
enforce its own laws. Accordingly, this
rulemaking does not have federalism
implications warranting the application
of Executive Order 13132.
Unfunded Mandates Reform Act of
1995
This rule will not result in the
expenditure by State, local, and tribal
governments, in the aggregate, or by the
private sector, of $114,540,000
(inflation-adjusted to 2003) or more in
any one year, and will not significantly
or uniquely affect small governments.
Therefore, no actions were deemed
necessary under the provisions of the
Unfunded Mandates Reform Act of
1995.
List of Subjects
21 CFR Part 1305
Drug traffic control, Reporting
requirements.
21 CFR Part 1311
Administrative practice and
procedure, Certification authorities,
Controlled substances, Digital
certificates, Drug traffic control,
Electronic signatures, Incorporation by
reference, Prescription drugs, Reporting
and recordkeeping requirements.
I For the reasons set out above, 21 CFR
Part 1305 is revised, and Part 1311 is
added as follows:
I 1. Part 1305 is revised to read as
follows:
PART 1305—ORDERS FOR SCHEDULE
I AND II CONTROLLED SUBSTANCES
Subpart A—General Requirements
Sec.
1305.01 Scope of part 1305.
1305.02 Definitions.
1305.03 Distributions requiring a Form 222
or digitally signed electronic order.
1305.04 Persons entitled to order Schedule
I and II controlled substances.
1305.05 Power of attorney.
1305.06 Persons entitled to fill orders for
Schedule I and II controlled substances.
1305.07 Special procedure for filling certain
orders.
Subpart B—DEA Form 222
1305.11 Procedure for obtaining DEA Forms
222.
1305.12 Procedure for executing DEA
Forms 222.
1305.13 Procedure for filling DEA Forms
222.
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
16911
1305.14 Procedure for endorsing DEA
Forms 222.
1305.15 Unaccepted and defective DEA
Forms 222.
1305.16 Lost and stolen DEA Forms 222.
1305.17 Preservation of DEA Forms 222.
1305.18 Return of unused DEA Forms 222.
1305.19 Cancellation and voiding of DEA
Forms 222.
Subpart C—Electronic Orders
1305.21 Requirements for electronic orders.
1305.22 Procedure for filling electronic
orders.
1305.23 Endorsing electronic orders.
1305.24 Central processing of orders.
1305.25 Unaccepted and defective
electronic orders.
1305.26 Lost electronic orders.
1305.27 Preservation of electronic orders.
1305.28 Canceling and voiding electronic
orders.
1305.29 Reporting to DEA.
Authority: 21 U.S.C. 821, 828, 871(b),
unless otherwise noted.
Subpart A—General Requirements
§ 1305.01
Scope of part 1305.
Procedures governing the issuance,
use, and preservation of orders for
Schedule I and II controlled substances
are set forth generally by section 308 of
the Act (21 U.S.C. 828) and specifically
by the sections of this part.
§ 1305.02
Definitions.
Any term contained in this part shall
have the definition set forth in the Act
or part 1300 of this chapter.
§ 1305.03 Distributions requiring a Form
222 or a digitally signed electronic order.
Either a DEA Form 222 or its
electronic equivalent as set forth in
subpart C of this part and Part 1311 of
this chapter is required for each
distribution of a Schedule I or II
controlled substance except for the
following:
(a) Distributions to persons exempted
from registration under Part 1301 of this
chapter.
(b) Exports from the United States that
conform with the requirements of the
Act.
(c) Deliveries to a registered analytical
laboratory or its agent approved by DEA.
(d) Delivery from a central fill
pharmacy, as defined in § 1300.01(b)(44)
of this chapter, to a retail pharmacy.
§ 1305.04 Persons entitled to order
Schedule I and II controlled substances.
(a) Only persons who are registered
with DEA under section 303 of the Act
(21 U.S.C. 823) to handle Schedule I or
II controlled substances, and persons
who are registered with DEA under
section 1008 of the Act (21 U.S.C. 958)
to export these substances may obtain
and use DEA Form 222 (order forms) or
E:\FR\FM\01APR2.SGM
01APR2
16912
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
issue electronic orders for these
substances. Persons not registered to
handle Schedule I or II controlled
substances and persons registered only
to import controlled substances are not
entitled to obtain Form 222 or issue
electronic orders for these substances.
(b) An order for Schedule I or II
controlled substances may be executed
only on behalf of the registrant named
on the order and only if his or her
registration for the substances being
purchased has not expired or been
revoked or suspended.
§ 1305.05
Power of attorney.
(a) A registrant may authorize one or
more individuals, whether or not
located at his or her registered location,
to issue orders for Schedule I and II
controlled substances on the registrant’s
behalf by executing a power of attorney
for each such individual, if the power of
attorney is retained in the files, with
executed Forms 222 where applicable,
for the same period as any order bearing
the signature of the attorney. The power
of attorney must be available for
inspection together with other order
records.
(b) A registrant may revoke any power
of attorney at any time by executing a
notice of revocation.
(c) The power of attorney and notice
of revocation must be similar to the
following format:
Power of Attorney for DEA Forms 222
and Electronic Orders
lllllllllllllllllllll
(Name of registrant)
lllllllllllllllllllll
(Address of registrant)
lllllllllllllllllllll
(DEA registration number)
I, llll (name of person granting
power), the undersigned, who am
authorized to sign the current
application for registration of the abovenamed registrant under the Controlled
Substances Act or Controlled
Substances Import and Export Act, have
made, constituted, and appointed, and
by these presents, do make, constitute,
and appoint llll (name of attorneyin-fact), my true and lawful attorney for
me in my name, place, and stead, to
execute applications for Forms 222 and
to sign orders for Schedule I and II
controlled substances, whether these
orders be on Form 222 or electronic, in
accordance with 21 U.S.C. 828 and Part
1305 of Title 21 of the Code of Federal
Regulations. I hereby ratify and confirm
all that said attorney must lawfully do
or cause to be done by virtue hereof.
lllllllllllllllllllll
(Signature of person granting power)
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
I, llll (name of attorney-in-fact),
hereby affirm that I am the person
named herein as attorney-in-fact and
that the signature affixed hereto is my
signature.
(signature of attorney-in-fact)
either a DEA Form 222 or an electronic
order may return the substance to the
supplier of the substance with either a
DEA Form 222 or an electronic order
from the supplier.
(c) A person registered to dispense
Schedule II substances may distribute
Witnesses:
the substances to another dispenser
1. llllll
with either a DEA Form 222 or an
2. llllll
electronic order only in the
circumstances described in § 1307.11 of
Signed and dated on the llll day
this chapter.
of llll, (year), at llll .
(d) A person registered or authorized
Notice of Revocation
to conduct chemical analysis or research
with controlled substances may
The foregoing power of attorney is
distribute a Schedule I or II controlled
hereby revoked by the undersigned,
substance to another person registered
who is authorized to sign the current
application for registration of the above- or authorized to conduct chemical
analysis, instructional activities, or
named registrant under the Controlled
research with the substances with either
Substances Act or the Controlled
a DEA Form 222 or an electronic order,
Substances Import and Export Act.
if the distribution is for the purpose of
Written notice of this revocation has
furthering the chemical analysis,
been given to the attorney-in-fact
instructional activities, or research.
llll this same day.
(e) A person registered as a
lllllllllllllllllllll
compounder of narcotic substances for
(Signature of person revoking power)
use at off-site locations in conjunction
Witnesses:
with a narcotic treatment program at the
1. llllll
compounding location, who is
2. llllll
authorized to handle Schedule II
Signed and dated on the llll day of
narcotics, is authorized to fill either a
llll , (year), at llll .
DEA Form 222 or an electronic order for
(d) A power of attorney must be
distribution of narcotic drugs to off-site
executed by the person who signed the
narcotic treatment programs only.
most recent application for DEA
registration or reregistration; the person § 1305.07 Special procedure for filling
certain orders.
to whom the power of attorney is being
granted; and two witnesses.
A supplier of carfentanil, etorphine
(e) A power of attorney must be
hydrochloride, or diprenorphine, if he
revoked by the person who signed the
or she determines that the purchaser is
most recent application for DEA
a veterinarian engaged in zoo and exotic
registration or reregistration, and two
animal practice, wildlife management
witnesses.
programs, or research, and is authorized
by the Administrator to handle these
§ 1305.06 Persons entitled to fill orders for
substances, may fill the order in
Schedule I and II controlled substances.
accordance with the procedures set
An order for Schedule I and II
forth in § 1305.17 except that:
controlled substances, whether on a
(a) A DEA Form 222 or an electronic
DEA Form 222 or an electronic order,
order for carfentanil, etorphine
may be filled only by a person registered
hydrochloride, and diprenorphine must
with DEA as a manufacturer or
contain only these substances in
distributor of controlled substances
reasonable quantities.
listed in Schedule I or II pursuant to
(b) The substances must be shipped,
section 303 of the Act (21 U.S.C. 823)
under secure conditions using
or as an importer of such substances
substantial packaging material with no
pursuant to section 1008 of the Act (21
markings on the outside that would
U.S.C. 958), except for the following:
indicate the content, only to the
(a) A person registered with DEA to
purchaser’s registered location.
dispense the substances, or to export the
substances, if he/she is discontinuing
Subpart B—DEA Form 222
business or if his/her registration is
§ 1305.11 Procedure for obtaining DEA
expiring without reregistration, may
Forms 222.
dispose of any Schedule I or II
controlled substances in his/her
(a) DEA Forms 222 are issued in
possession with a DEA Form 222 or an
mailing envelopes containing either
electronic order in accordance with
seven or fourteen forms, each form
§ 1301.52 of this chapter.
containing an original, duplicate, and
(b) A purchaser who has obtained any triplicate copy (respectively, Copy 1,
Schedule I or II controlled substance by Copy 2, and Copy 3). A limit, which is
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
based on the business activity of the
registrant, will be imposed on the
number of DEA Forms 222, which will
be furnished on any requisition unless
additional forms are specifically
requested and a reasonable need for
such additional forms is shown.
(b) Any person applying for a
registration that would entitle him or
her to obtain a DEA Form 222 may
requisition the forms by so indicating on
the application form; a DEA Form 222
will be supplied upon the registration of
the applicant. Any person holding a
registration entitling him or her to
obtain a DEA Form 222 may requisition
the forms for the first time by contacting
any Division Office or the Registration
Section of the Administration. Any
person already holding a DEA Form 222
may requisition additional forms on
DEA Form 222a, which is mailed to a
registrant approximately 30 days after
each shipment of DEA Forms 222 to that
registrant, or by contacting any Division
Office or the Registration Section of the
Administration. All requisition forms
(DEA Form 222a) must be submitted to
the DEA Registration Section.
(c) Each requisition must show the
name, address, and registration number
of the registrant and the number of
books of DEA Forms 222 desired. Each
requisition must be signed and dated by
the same person who signed the most
recent application for registration or for
reregistration, or by any person
authorized to obtain and execute DEA
Forms 222 by a power of attorney under
§ 1305.05.
(d) DEA Forms 222 will be serially
numbered and issued with the name,
address, and registration number of the
registrant, the authorized activity, and
schedules of the registrant. This
information cannot be altered or
changed by the registrant; any errors
must be corrected by the Registration
Section of the Administration by
returning the forms with notification of
the error.
§ 1305.12 Procedure for executing DEA
Forms 222.
(a) A purchaser must prepare and
execute a DEA Form 222 simultaneously
in triplicate by means of interleaved
carbon sheets that are part of the DEA
Form 222. DEA Form 222 must be
prepared by use of a typewriter, pen, or
indelible pencil.
(b) Only one item may be entered on
each numbered line. An item must
consist of one or more commercial or
bulk containers of the same finished or
bulk form and quantity of the same
substance. The number of lines
completed must be noted on that form
at the bottom of the form, in the space
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
provided. DEA Forms 222 for
carfentanil, etorphine hydrochloride,
and diprenorphine must contain only
these substances.
(c) The name and address of the
supplier from whom the controlled
substances are being ordered must be
entered on the form. Only one supplier
may be listed on any form.
(d) Each DEA Form 222 must be
signed and dated by a person authorized
to sign an application for registration or
a person granted power of attorney to
sign a Form 222 under § 1305.05. The
name of the purchaser, if different from
the individual signing the DEA Form
222, must also be inserted in the
signature space.
(e) Unexecuted DEA Forms 222 may
be kept and may be executed at a
location other than the registered
location printed on the form, provided
that all unexecuted forms are delivered
promptly to the registered location upon
an inspection of the location by any
officer authorized to make inspections,
or to enforce, any Federal, State, or local
law regarding controlled substances.
§ 1305.13
222.
Procedure for filling DEA Forms
(a) A purchaser must submit Copy 1
and Copy 2 of the DEA Form 222 to the
supplier and retain Copy 3 in the
purchaser’s files.
(b) A supplier may fill the order, if
possible and if the supplier desires to do
so, and must record on Copies 1 and 2
the number of commercial or bulk
containers furnished on each item and
the date on which the containers are
shipped to the purchaser. If an order
cannot be filled in its entirety, it may be
filled in part and the balance supplied
by additional shipments within 60 days
following the date of the DEA Form 222.
No DEA Form 222 is valid more than 60
days after its execution by the
purchaser, except as specified in
paragraph (f) of this section.
(c) The controlled substances must be
shipped only to the purchaser and the
location printed by the Administration
on the DEA Form 222, except as
specified in paragraph (f) of this section.
(d) The supplier must retain Copy 1
of the DEA Form 222 for his or her files
and forward Copy 2 to the Special Agent
in Charge of the Drug Enforcement
Administration in the area in which the
supplier is located. Copy 2 must be
forwarded at the close of the month
during which the order is filled. If an
order is filled by partial shipments,
Copy 2 must be forwarded at the close
of the month during which the final
shipment is made or the 60-day validity
period expires.
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
16913
(e) The purchaser must record on
Copy 3 of the DEA Form 222 the
number of commercial or bulk
containers furnished on each item and
the dates on which the containers are
received by the purchaser.
(f) DEA Forms 222 submitted by
registered procurement officers of the
Defense Supply Center of the Defense
Logistics Agency for delivery to armed
services establishments within the
United States may be shipped to
locations other than the location printed
on the DEA Form 222, and in partial
shipments at different times not to
exceed six months from the date of the
order, as designated by the procurement
officer when submitting the order.
§ 1305.14 Procedure for endorsing DEA
Forms 222.
(a) A DEA Form 222, made out to any
supplier who cannot fill all or a part of
the order within the time limitation set
forth in § 1305.13, may be endorsed to
another supplier for filling. The
endorsement must be made only by the
supplier to whom the DEA Form 222
was first made, must state (in the spaces
provided on the reverse sides of Copies
1 and 2 of the DEA Form 222) the name
and address of the second supplier, and
must be signed by a person authorized
to obtain and execute DEA Forms 222
on behalf of the first supplier. The first
supplier may not fill any part of an
order on an endorsed form. The second
supplier may fill the order, if possible
and if the supplier desires to do so, in
accordance with § 1305.13(b), (c), and
(d), including shipping all substances
directly to the purchaser.
(b) Distributions made on endorsed
DEA Forms 222 must be reported by the
second supplier in the same manner as
all other distributions except that where
the name of the supplier is requested on
the reporting form, the second supplier
must record the name, address, and
registration number of the first supplier.
§ 1305.15 Unaccepted and defective DEA
Forms 222.
(a) A DEA Form 222 must not be filled
if either of the following apply:
(1) The order is not complete, legible,
or properly prepared, executed, or
endorsed.
(2) The order shows any alteration,
erasure, or change of any description.
(b) If a DEA Form 222 cannot be filled
for any reason under this section, the
supplier must return Copies 1 and 2 to
the purchaser with a statement as to the
reason (e.g., illegible or altered).
(c) A supplier may for any reason
refuse to accept any order and if a
supplier refuses to accept the order, a
statement that the order is not accepted
E:\FR\FM\01APR2.SGM
01APR2
16914
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
is sufficient for purposes of this
paragraph.
(d) When a purchaser receives an
unaccepted order, Copies 1 and 2 of the
DEA Form 222 and the statement must
be attached to Copy 3 and retained in
the files of the purchaser in accordance
with § 1305.17. A defective DEA Form
222 may not be corrected; it must be
replaced by a new DEA Form 222 for the
order to be filled.
§ 1305.16
Lost and stolen DEA Forms 222.
(a) If a purchaser ascertains that an
unfilled DEA Form 222 has been lost, he
or she must execute another in triplicate
and attach a statement containing the
serial number and date of the lost form,
and stating that the goods covered by
the first DEA Form 222 were not
received through loss of that DEA Form
222. Copy 3 of the second form and a
copy of the statement must be retained
with Copy 3 of the DEA Form 222 first
executed. A copy of the statement must
be attached to Copies 1 and 2 of the
second DEA Form 222 sent to the
supplier. If the first DEA Form 222 is
subsequently received by the supplier to
whom it was directed, the supplier must
mark upon the face ‘‘Not accepted’’ and
return Copies 1 and 2 to the purchaser,
who must attach it to Copy 3 and the
statement.
(b) Whenever any used or unused
DEA Forms 222 are stolen or lost (other
than in the course of transmission) by
any purchaser or supplier, the purchaser
or supplier must immediately upon
discovery of the theft or loss, report the
theft or loss to the Special Agent in
Charge of the Drug Enforcement
Administration in the Divisional Office
responsible for the area in which the
registrant is located, stating the serial
number of each form stolen or lost.
(c) If the theft or loss includes any
original DEA Forms 222 received from
purchasers and the supplier is unable to
state the serial numbers of the DEA
Forms 222, the supplier must report the
date or approximate date of receipt and
the names and addresses of the
purchasers.
(d) If an entire book of DEA Forms
222 is lost or stolen, and the purchaser
is unable to state the serial numbers of
the DEA Forms 222 in the book, the
purchaser must report, in lieu of the
numbers of the forms contained in the
book, the date or approximate date of
issuance.
(e) If any unused DEA Form 222
reported stolen or lost is subsequently
recovered or found, the Special Agent in
Charge of the Drug Enforcement
Administration in the Divisional Office
responsible for the area in which the
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
registrant is located must immediately
be notified.
§ 1305.17
Preservation of DEA Forms 222.
(a) The purchaser must retain Copy 3
of each executed DEA Form 222 and all
copies of unaccepted or defective forms
with each statement attached.
(b) The supplier must retain Copy 1
of each DEA Form 222 that it has filled.
(c) DEA Forms 222 must be
maintained separately from all other
records of the registrant. DEA Forms 222
are required to be kept available for
inspection for a period of two years. If
a purchaser has several registered
locations, the purchaser must retain
Copy 3 of the executed DEA Form 222
and any attached statements or other
related documents (not including
unexecuted DEA Forms 222, which may
be kept elsewhere under § 1305.12(e)),
at the registered location printed on the
DEA Form 222.
(d) The supplier of carfentanil,
etorphine hydrochloride, and
diprenorphine must maintain DEA
Forms 222 for these substances
separately from all other DEA Forms
222 and records required to be
maintained by the registrant.
§ 1305.18
222.
Return of unused DEA Forms
If the registration of any purchaser
terminates (because the purchaser dies,
ceases legal existence, discontinues
business or professional practice, or
changes the name or address as shown
on the purchaser’s registration) or is
suspended or revoked under § 1301.36
of this chapter for all Schedule I and II
controlled substances for which the
purchaser is registered, the purchaser
must return all unused DEA Forms 222
to the nearest office of the
Administration.
§ 1305.19 Cancellation and voiding of DEA
Forms 222.
(a) A purchaser may cancel part or all
of an order on a DEA Form 222 by
notifying the supplier in writing of the
cancellation. The supplier must indicate
the cancellation on Copies 1 and 2 of
the DEA Form 222 by drawing a line
through the canceled items and printing
‘‘canceled’’ in the space provided for
number of items shipped.
(b) A supplier may void part or all of
an order on a DEA Form 222 by
notifying the purchaser in writing of the
voiding. The supplier must indicate the
voiding in the manner prescribed for
cancellation in paragraph (a) of this
section.
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
Subpart C—Electronic Orders
§ 1305.21
orders.
Requirements for electronic
(a) To be valid, the purchaser must
sign an electronic order for a Schedule
I or II controlled substance with a digital
signature issued to the purchaser, or the
purchaser’s agent, by DEA as provided
in part 1311 of this chapter.
(b) The following data fields must be
included on an electronic order for
Schedule I and II controlled substances:
(1) A unique number the purchaser
assigns to track the order. The number
must be in the following 9-character
format: the last two digits of the year, X,
and six characters as selected by the
purchaser.
(2) The purchaser’s DEA registration
number.
(3) The name of the supplier.
(4) The complete address of the
supplier (may be completed by either
the purchaser or the supplier).
(5) The supplier’s DEA registration
number (may be completed by either the
purchaser or the supplier).
(6) The date the order is signed.
(7) The name (including strength
where appropriate) of the controlled
substance product or the National Drug
Code (NDC) number (the NDC number
may be completed by either the
purchaser or the supplier).
(8) The quantity in a single package or
container.
(9) The number of packages or
containers of each item ordered.
(c) An electronic order may include
controlled substances that are not in
schedules I and II and non-controlled
substances.
§ 1305.22
orders.
Procedure for filling electronic
(a) A purchaser must submit the order
to a specific supplier. The supplier may
initially process the order (e.g., entry of
the order into the computer system,
billing functions, inventory
identification, etc.) centrally at any
location, regardless of the location’s
registration with DEA. Following
centralized processing, the supplier may
distribute the order to one or more
registered locations maintained by the
supplier for filling. The registrant must
maintain control of the processing of the
order at all times.
(b) A supplier may fill the order for
a Schedule I or II controlled substance,
if possible and if the supplier desires to
do so and is authorized to do so under
§ 1305.06.
(c) A supplier must do the following
before filling the order:
(1) Verify the integrity of the signature
and the order by using software that
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
complies with Part 1311 of this chapter
to validate the order.
(2) Verify that the digital certificate
has not expired.
(3) Check the validity of the certificate
holder’s certificate by checking the
Certificate Revocation List. The supplier
may cache the Certificate Revocation
List until it expires.
(4) Verify the registrant’s eligibility to
order the controlled substances by
checking the certificate extension data.
(d) The supplier must retain an
electronic record of every order, and,
linked to each order, a record of the
number of commercial or bulk
containers furnished on each item and
the date on which the supplier shipped
the containers to the purchaser. The
linked record must also include any
data on the original order that the
supplier completes. Software used to
handle digitally signed orders must
comply with part 1311 of this chapter.
(e) If an order cannot be filled in its
entirety, a supplier may fill it in part
and supply the balance by additional
shipments within 60 days following the
date of the order. No order is valid more
than 60 days after its execution by the
purchaser, except as specified in
paragraph (h) of this section.
(f) A supplier must ship the
controlled substances to the registered
location associated with the digital
certificate used to sign the order, except
as specified in paragraph (h) of this
section.
(g) When a purchaser receives a
shipment, the purchaser must create a
record of the quantity of each item
received and the date received. The
record must be electronically linked to
the original order and archived.
(h) Registered procurement officers of
the Defense Supply Center of the
Defense Logistics Agency may order
controlled substances for delivery to
armed services establishments within
the United States. These orders may be
shipped to locations other than the
registered location, and in partial
shipments at different times not to
exceed six months from the date of the
order, as designated by the procurement
officer when submitting the order.
§ 1305.23
Endorsing electronic orders.
A supplier may not endorse an
electronic order to another supplier to
fill.
§ 1305.24
Central processing of orders.
(a) A supplier that has one or more
registered locations and maintains a
central processing computer system in
which orders are stored may have one
or more of the supplier’s registered
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
locations fill an electronic order if the
supplier does the following:
(1) Assigns each item on the order to
a specific registered location for filling.
(2) Creates a record linked to the
central file noting both which items a
location filled and the location identity.
(3) Ensures that no item is filled by
more than one location.
(4) Maintains the original order with
all linked records on the central
computer system.
(b) A company that has central
processing of orders must assign
responsibility for filling parts of orders
only to registered locations that the
company owns and operates.
§ 1305.25 Unaccepted and defective
electronic orders.
(a) No electronic order may be filled
if:
(1) The required data fields have not
been completed.
(2) The order is not signed using a
digital certificate issued by DEA.
(3) The digital certificate used had
expired or had been revoked prior to
signature.
(4) The purchaser’s public key will
not validate the digital signature.
(5) The validation of the order shows
that the order is invalid for any reason.
(b) If an order cannot be filled for any
reason under this section, the supplier
must notify the purchaser and provide
a statement as to the reason (e.g.,
improperly prepared or altered). A
supplier may, for any reason, refuse to
accept any order, and if a supplier
refuses to accept the order, a statement
that the order is not accepted is
sufficient for purposes of this paragraph.
(c) When a purchaser receives an
unaccepted electronic order from the
supplier, the purchaser must
electronically link the statement of
nonacceptance to the original order. The
original order and the statement must be
retained in accordance with § 1305.27.
(d) Neither a purchaser nor a supplier
may correct a defective order; the
purchaser must issue a new order for
the order to be filled.
§ 1305.26
Lost electronic orders.
(a) If a purchaser determines that an
unfilled electronic order has been lost
before or after receipt, the purchaser
must provide, to the supplier, a signed
statement containing the unique
tracking number and date of the lost
order and stating that the goods covered
by the first order were not received
through loss of that order.
(b) If the purchaser executes an order
to replace the lost order, the purchaser
must electronically link an electronic
record of the second order and a copy
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
16915
of the statement with the record of the
first order and retain them.
(c) If the supplier to whom the order
was directed subsequently receives the
first order, the supplier must indicate
that it is ‘‘Not Accepted’’ and return it
to the purchaser. The purchaser must
link the returned order to the record of
that order and the statement.
§ 1305.27
orders.
Preservation of electronic
(a) A purchaser must, for each order
filled, retain the original signed order
and all linked records for that order for
two years. The purchaser must also
retain all copies of each unaccepted or
defective order and each linked
statement.
(b) A supplier must retain each
original order filled and the linked
records for two years.
(c) If electronic order records are
maintained on a central server, the
records must be readily retrievable at
the registered location.
§ 1305.28
orders.
Canceling and voiding electronic
(a) A supplier may void all or part of
an electronic order by notifying the
purchaser of the voiding. If the entire
order is voided, the supplier must make
an electronic copy of the order, indicate
on the copy ‘‘Void,’’ and return it to the
purchaser. The supplier is not required
to retain a record of orders that are not
filled.
(b) The purchaser must retain an
electronic copy of the voided order.
(c) To partially void an order, the
supplier must indicate in the linked
record that nothing was shipped for
each item voided.
§ 1305.29
Reporting to DEA.
A supplier must, for each electronic
order filled, forward either a copy of the
electronic order or an electronic report
of the order in a format that DEA
specifies to DEA within two business
days.
I 2. Part 1311 is added to read as follows:
PART 1311 ‘‘DIGITAL CERTIFICATES
Subpart A—General
Sec.
1311.01 Scope.
1311.02 Definitions.
1311.05 Standards for technologies for
electronic transmission of orders.
1311.08 Incorporation by reference.
Subpart B—Obtaining and Using Digital
Certificates for Electronic Orders
1311.10 Eligibility to obtain a CSOS digital
certificate.
1311.15 Limitations on CSOS digital
certificates.
1311.20 Coordinators for CSOS digital
certificate holders.
E:\FR\FM\01APR2.SGM
01APR2
16916
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
1311.25 Requirements for obtaining a CSOS
digital certificate.
1311.30 Requirements for storing and using
a private key for digitally signing orders.
1311.35 Number of CSOS digital certificates
needed.
1311.40 Renewal of CSOS digital
certificates.
1311.45 Requirements for registrants that
allow powers of attorney to obtain CSOS
digital certificates under their DEA
registration.
1311.50 Requirements for recipients of
digitally signed orders.
1311.55 Requirements for systems used to
process digitally signed orders.
1311.60 Recordkeeping.
Authority: 21 U.S.C. 821, 828, 829, 871(b),
958(e), 965, unless otherwise noted.
Subpart A—General
§ 1311.01
Scope.
This part sets forth the rules
governing the use of digital signatures
and the protection of private keys by
registrants.
§ 1311.02
Definitions.
For the purposes of this chapter:
Biometric authentication means
authentication based on measurement of
the individual’s physical features or
repeatable actions where those features
or actions are both unique to the
individual and measurable.
Cache means to download and store
information on a local server or hard
drive.
Certificate Policy means a named set
of rules that sets forth the applicability
of the specific digital certificate to a
particular community or class of
application with common security
requirements.
Certificate Revocation List (CRL)
means a list of revoked, but unexpired
certificates issued by a Certification
Authority.
Certification Authority (CA) means an
organization that is responsible for
verifying the identity of applicants,
authorizing and issuing a digital
certificate, maintaining a directory of
public keys, and maintaining a
Certificate Revocation List.
CSOS means controlled substance
ordering system.
Digital certificate means a data record
that, at a minimum:
(1) Identifies the certification
authority issuing it;
(2) Names or otherwise identifies the
certificate holder;
(3) Contains a public key that
corresponds to a private key under the
sole control of the certificate holder;
(4) Identifies the operational period;
and
(5) Contains a serial number and is
digitally signed by the Certification
Authority issuing it.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
Digital signature means a record
created when a file is algorithmically
transformed into a fixed length digest
that is then encrypted using an
asymmetric cryptographic private key
associated with a digital certificate. The
combination of the encryption and
algorithm transformation ensure that the
signer’s identity and the integrity of the
file can be confirmed.
Electronic signature means a method
of signing an electronic message that
identifies a particular person as the
source of the message and indicates the
person’s approval of the information
contained in the message.
FIPS means Federal Information
Processing Standards. These Federal
standards, as incorporated by reference
in § 1311.08, prescribe specific
performance requirements, practices,
formats, communications protocols, etc.,
for hardware, software, data, etc.
FIPS 140–2, as incorporated by
reference in § 1311.08, means a Federal
standard for security requirements for
cryptographic modules.
FIPS 180–2, as incorporated by
reference in § 1311.08, means a Federal
secure hash standard.
FIPS 186–2, as incorporated by
reference in § 1311.08, means a Federal
standard for applications used to
generate and rely upon digital
signatures.
Key pair means two mathematically
related keys having the properties that:
(1) One key can be used to encrypt a
message that can only be decrypted
using the other key; and
(2) Even knowing one key, it is
computationally infeasible to discover
the other key.
NIST means the National Institute of
Standards and Technology.
Private key means the key of a key
pair that is used to create a digital
signature.
Public key means the key of a key pair
that is used to verify a digital signature.
The public key is made available to
anyone who will receive digitally signed
messages from the holder of the key
pair.
Public Key Infrastructure (PKI) means
a structure under which a Certification
Authority verifies the identity of
applicants, issues, renews, and revokes
digital certificates, maintains a registry
of public keys, and maintains an up-todate Certificate Revocation List.
§ 1311.05 Standards for technologies for
electronic transmission of orders.
(a) A registrant or a person with
power of attorney to sign orders for
Schedule I and II controlled substances
may use any technology to sign and
electronically transmit orders if the
technology provides all of the following:
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
(1) Authentication: The system must
enable a recipient to positively verify
the signer without direct
communication with the signer and
subsequently demonstrate to a third
party, if needed, that the sender’s
identity was properly verified.
(2) Nonrepudiation: The system must
ensure that strong and substantial
evidence is available to the recipient of
the sender’s identity, sufficient to
prevent the sender from successfully
denying having sent the data. This
criterion includes the ability of a third
party to verify the origin of the
document.
(3) Message integrity: The system
must ensure that the recipient, or a third
party, can determine whether the
contents of the document have been
altered during transmission or after
receipt.
(b) DEA has identified the following
means of electronically signing and
transmitting order forms as meeting all
of the standards set forth in paragraph
(a) of this section.
(1) Digital signatures using Public Key
Infrastructure (PKI) technology.
(2) [Reserved]
§ 1311.08
Incorporation by reference.
(a) The following standards are
incorporated by reference:
(1) FIPS 140–2, Security
Requirements for Cryptographic
Modules, May 25, 2001, as amended by
Change Notices 2 through 4, December
3, 2002.
(i) Annex A: Approved Security
Functions for FIPS PUB 140–2, Security
Requirements for Cryptographic
Modules, September 23, 2004.
(ii) Annex B: Approved Protection
Profiles for FIPS PUB 140–2, Security
Requirements for Cryptographic
Modules, November 4, 2004.
(iii) Annex C: Approved Random
Number Generators for FIPS PUB 140–
2, Security Requirements for
Cryptographic Modules, January 31,
2005.
(iv) Annex D: Approved Key
Establishment Techniques for FIPS PUB
140–2, Security Requirements for
Cryptographic Modules, February 23,
2004.
(2) FIPS 180–2, Secure Hash
Standard, August 1, 2002, as amended
by change notice 1, February 25, 2004.
(3) FIPS 186–2, Digital Signature
Standard, January 27, 2000, as amended
by Change Notice 1, October 5, 2001.
(b) These standards are available from
the National Institute of Standards and
Technology, Computer Security
Division, Information Technology
Laboratory, National Institute of
Standards and Technology, 100
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
Bureau Drive, Gaithersburg, MD 20899–
8930 and are available at https://
csrc.nist.gov/.
(c) These incorporations by reference
were approved by the Director of the
Federal Register in accordance with 5
U.S.C. 552(a) and 1 CFR part 51. Copies
may be inspected at the Drug
Enforcement Administration, 600 Army
Navy Drive, Arlington, VA 22202 or at
the National Archives and Records
Administration (NARA). For
information on the availability of this
material at NARA, call (202) 741–6030,
or go to: https://www.archives.gov/
federal_register/
code_of_federal_regulations/
ibr_locations.html.
Subpart B—Obtaining and Using
Digital Certificates for Electronic
Orders
§ 1311.10 Eligibility to obtain a CSOS
digital certificate.
The following persons are eligible to
obtain a CSOS digital certificate from
the DEA Certification Authority to sign
electronic orders for controlled
substances.
(a) The person who signed the most
recent DEA registration application or
renewal application and a person
authorized to sign a registration
application.
(b) A person granted power of
attorney by a DEA registrant to sign
orders for one or more schedules of
controlled substances.
§ 1311.15 Limitations on CSOS digital
certificates.
(a) A CSOS digital certificate issued
by the DEA Certification Authority will
authorize the certificate holder to sign
orders for only those schedules of
controlled substances covered by the
registration under which the certificate
is issued.
(b) When a registrant, in a power of
attorney letter, limits a certificate
applicant to a subset of the registrant’s
authorized schedules, the registrant is
responsible for ensuring that the
certificate holder signs orders only for
that subset of schedules.
§ 1311.20 Coordinators for CSOS digital
certificate holders.
(a) Each registrant, regardless of
number of digital certificates issued,
must designate one or more responsible
persons to serve as that registrant’s
CSOS coordinator regarding issues
pertaining to issuance of, revocation of,
and changes to digital certificates issued
under that registrant’s DEA registration.
While the coordinator will be the main
point of contact between one or more
DEA registered locations and the CSOS
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
Certification Authority, all digital
certificate activities are the
responsibility of the registrant with
whom the digital certificate is
associated. Even when an individual
registrant, i.e., an individual
practitioner, is applying for a digital
certificate to order controlled substances
a CSOS Coordinator must be designated;
though in such a case, the individual
practitioner may also serve as the
coordinator.
(b) Once designated, coordinators
must identify themselves, on a one-time
basis, to the Certification Authority. If a
designated coordinator changes, the
Certification Authority must be notified
of the change and the new
responsibilities assumed by each of the
registrant’s coordinators, if applicable.
Coordinators must complete the
application that the DEA Certification
Authority provides and submit the
following:
(1) Two copies of identification, one
of which must be a government-issued
photographic identification.
(2) A copy of each current DEA
Certificate of Registration (DEA form
223) for each registered location for
which the coordinator will be
responsible or, if the applicant (or their
employer) has not been issued a DEA
registration, a copy of each application
for registration of the applicant or the
applicant’s employer.
(3) The applicant must have the
completed application notarized and
forward the completed application and
accompanying documentation to the
DEA Certification Authority.
(c) Coordinators will communicate
with the Certification Authority
regarding digital certificate applications,
renewals and revocations. For
applicants applying for a digital
certificate from the DEA Certification
Authority, and for applicants applying
for a power of attorney digital certificate
for a DEA registrant, the registrant’s
Coordinator must verify the applicant’s
identity, review the application
package, and submit the completed
package to the Certification Authority.
§ 1311.25 Requirements for obtaining a
CSOS digital certificate.
(a) To obtain a certificate to use for
signing electronic orders for controlled
substances, a registrant or person with
power of attorney for a registrant must
complete the application that the DEA
Certification Authority provides and
submit the following:
(1) Two copies of identification, one
of which must be a government-issued
photographic identification.
(2) A current listing of DEA
registrations for which the individual
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
16917
has authority to sign controlled
substances orders.
(3) A copy of the power of attorney
from the registrant, if applicable.
(4) An acknowledgment that the
applicant has read and understands the
Subscriber Agreement and agrees to the
statement of subscriber obligations that
DEA provides.
(b) The applicant must provide the
completed application to the registrant’s
coordinator for CSOS digital certificate
holders who will review the application
and submit the completed application
and accompanying documentation to
the DEA Certification Authority.
(c) When the Certification Authority
approves the application, it will send
the applicant a one-time use reference
number and access code, via separate
channels, and information on how to
use them. Using this information, the
applicant must then electronically
submit a request for certification of the
public digital signature key. After the
request is approved, the Certification
Authority will provide the applicant
with the signed public key certificate.
(d) Once the applicant has generated
the key pair, the Certification Authority
must prove that the user has possession
of the key. For public keys, the
corresponding private key must be used
to sign the certificate request.
Verification of the signature using the
public key in the request will serve as
proof of possession of the private key.
§ 1311.30 Requirements for storing and
using a private key for digitally signing
orders.
(a) Only the certificate holder may
access or use his or her digital certificate
and private key.
(b) The certificate holder must
provide FIPS-approved secure storage
for the private key, as discussed by FIPS
140–2, 180–2, 186–2, and accompanying
change notices and annexes, as
incorporated by reference in § 1311.08.
(c) A certificate holder must ensure
that no one else uses the private key.
While the private key is activated, the
certificate holder must prevent
unauthorized use of that private key.
(d) A certificate holder must not make
back-up copies of the private key.
(e) The certificate holder must report
the loss, theft, or compromise of the
private key or the password, via a
revocation request, to the Certification
Authority within 24 hours of
substantiation of the loss, theft, or
compromise. Upon receipt and
verification of a signed revocation
request, the Certification Authority will
revoke the certificate. The certificate
holder must apply for a new certificate
under the requirements of § 1311.25.
E:\FR\FM\01APR2.SGM
01APR2
16918
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
§ 1311.35 Number of CSOS digital
certificates needed.
A purchaser of Schedule I and II
controlled substances must obtain a
separate CSOS certificate for each
registered location for which the
purchaser will order these controlled
substances.
§ 1311.40 Renewal of CSOS digital
certificates.
(a) A CSOS certificate holder must
generate a new key pair and obtain a
new CSOS digital certificate when the
registrant’s DEA registration expires or
whenever the information on which the
certificate is based changes. This
information includes the registered
name and address, the subscriber’s
name, and the schedules the registrant
is authorized to handle. A CSOS
certificate will expire on the date on
which the DEA registration on which
the certificate is based expires.
(b) The Certification Authority will
notify each CSOS certificate holder 45
days in advance of the expiration of the
certificate holder’s CSOS digital
certificate.
(c) If a CSOS certificate holder applies
for a renewal before the certificate
expires, the certificate holder may
renew electronically twice. For every
third renewal, the CSOS certificate
holder must submit a new application
and documentation, as provided in
§ 1311.25.
(d) If a CSOS certificate expires before
the holder applies for a renewal, the
certificate holder must submit a new
application and documentation, as
provided in § 1311.25.
§ 1311.45 Requirements for registrants
that allow powers of attorney to obtain
CSOS digital certificates under their DEA
registration.
(a) A registrant that grants power of
attorney must report to the DEA
Certification Authority within 6 hours
of either of the following (advance
notice may be provided, where
applicable):
(1) The person with power of attorney
has left the employ of the institution.
(2) The person with power of attorney
has had his or her privileges revoked.
(b) A registrant must maintain a
record that lists each person granted
power of attorney to sign controlled
substances orders.
§ 1311.50 Requirements for recipients of
digitally signed orders.
(a) The recipient of a digitally signed
order must do the following before
filling the order:
(1) Verify the integrity of the signature
and the order by having the system
validate the order.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
(2) Verify that the certificate holder’s
CSOS digital certificate has not expired
by checking the expiration date against
the date the order was signed.
(3) Check the validity of the certificate
holder’s certificate by checking the
Certificate Revocation List.
(4) Check the certificate extension
data to determine whether the sender
has the authority to order the controlled
substance.
(b) A recipient may cache Certificate
Revocation Lists for use until they
expire.
§ 1311.55 Requirements for systems used
to process digitally signed orders.
(a) A CSOS certificate holder and
recipient of an electronic order may use
any system to write, track, or maintain
orders provided that the system has
been enabled to process digitally signed
documents and that it meets the
requirements of paragraph (b) or (c) of
this section.
(b) A system used to digitally sign
Schedule I or II orders must meet the
following requirements:
(1) The cryptographic module must be
FIPS 140–2, Level 1 validated, as
incorporated by reference in § 1311.08.
(2) The digital signature system and
hash function must be compliant with
FIPS 186–2 and FIPS 180–2, as
incorporated by reference in § 1311.08.
(3) The private key must be stored on
a FIPS 140–2 Level 1 validated
cryptographic module using a FIPSapproved encryption algorithm, as
incorporated by reference in § 1311.08.
(4) The system must use either a user
identification and password
combination or biometric authentication
to access the private key. Activation
data must not be displayed as they are
entered.
(5) The system must set a 10-minute
inactivity time period after which the
certificate holder must reauthenticate
the password to access the private key.
(6) For software implementations,
when the signing module is deactivated,
the system must clear the plain text
private key from the system memory to
prevent the unauthorized access to, or
use of, the private key.
(7) The system must be able to
digitally sign and transmit an order.
(8) The system must have a time
system that is within five minutes of the
official National Institute of Standards
and Technology time source.
(9) The system must archive the
digitally signed orders and any other
records required in part 1305 of this
chapter, including any linked data.
(10) The system must create an order
that includes all data fields listed under
§ 1305.21(b) of this chapter.
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
(c) A system used to receive, verify,
and create linked records for orders
signed with a CSOS digital certificate
must meet the following requirements:
(1) The cryptographic module must be
FIPS 140–2, Level 1 validated, as
incorporated by reference in § 1311.08.
(2) The digital signature system and
hash function must be compliant with
FIPS 186–2 and FIPS 180–2, as
incorporated by reference in § 1311.08.
(3) The system must determine that an
order has not been altered during
transmission. The system must
invalidate any order that has been
altered.
(4) The system must validate the
digital signature using the signer’s
public key. The system must invalidate
any order in which the digital signature
cannot be validated.
(5) The system must validate that the
DEA registration number contained in
the body of the order corresponds to the
registration number associated with the
specific certificate by separately
generating the hash value of the
registration number and certificate
subject distinguished name serial
number and comparing that hash value
to the hash value contained in the
certificate extension for the DEA
registration number. If the hash values
are not equal the system must invalidate
the order.
(6) The system must check the
Certificate Revocation List automatically
and invalidate any order with a
certificate listed on the Certificate
Revocation List.
(7) The system must check the
validity of the certificate and the
Certification Authority certificate and
invalidate any order that fails these
validity checks.
(8) The system must have a time
system that is within five minutes of the
official National Institute of Standards
and Technology time source.
(9) The system must check the
substances ordered against the
schedules that the registrant is allowed
to order and invalidate any order that
includes substances the registrant is not
allowed to order.
(10) The system must ensure that an
invalid finding cannot be bypassed or
ignored and the order filled.
(11) The system must archive the
order and associate with it the digital
certificate received with the order.
(12) If a registrant sends reports on
orders to DEA, the system must create
a report in the format DEA specifies, as
provided in § 1305.29 of this chapter.
(d) For systems used to process CSOS
orders, the system developer or vendor
must have an initial independent thirdparty audit of the system and an
E:\FR\FM\01APR2.SGM
01APR2
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules and Regulations
additional independent third-party
audit whenever the signing or verifying
functionality is changed to determine
whether it correctly performs the
functions listed under paragraphs (b)
and (c) of this section. The system
developer must retain the most recent
audit results and retain the results of
any other audits of the software
completed within the previous two
years.
VerDate jul<14>2003
17:27 Mar 31, 2005
Jkt 205001
§ 1311.60
Recordkeeping.
(a) A supplier and purchaser must
maintain records of CSOS electronic
orders and any linked records for two
years. Records may be maintained
electronically. Records regarding
controlled substances that are
maintained electronically must be
readily retrievable from all other
records.
(b) Electronic records must be easily
readable or easily rendered into a format
that a person can read. They must be
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
16919
made available to the Administration
upon request.
(c) CSOS certificate holders must
maintain a copy of the subscriber
agreement that the Certification
Authority provides for the life of the
certificate.
Dated: March 28, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05–6504 Filed 3–31–05; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\01APR2.SGM
01APR2
Agencies
[Federal Register Volume 70, Number 62 (Friday, April 1, 2005)]
[Rules and Regulations]
[Pages 16902-16919]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6504]
[[Page 16901]]
-----------------------------------------------------------------------
Part II
Department of Justice
-----------------------------------------------------------------------
Drug Enforcement Administration
-----------------------------------------------------------------------
21 CFR Parts 1305 and 1311
Electronic Orders for Controlled Substances and Notice of Meeting;
Final Rule and Notice
Federal Register / Vol. 70, No. 62 / Friday, April 1, 2005 / Rules
and Regulations
[[Page 16902]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Parts 1305 and 1311
[Docket No. DEA-217F]
RIN 1117-AA60
Electronic Orders for Controlled Substances
AGENCY: Drug Enforcement Administration (DEA), Justice.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: DEA is revising its regulations to provide an electronic
equivalent to the DEA official order form, which is legally required
for all distributions involving Schedule I and II controlled
substances. These regulations will allow, but not require, registrants
to order Schedule I and II substances electronically and maintain the
records of these orders electronically. The regulations will reduce
paperwork and transaction times for DEA registrants who handle, sell,
or buy these controlled substances. This rule has no effect on
patients' ability to receive prescriptions for controlled substances
from practitioners, nor on their ability to have those prescriptions
filled at pharmacies.
DATES: Effective Date: This rule is effective on May 31, 2005. The
incorporation by reference of certain publications listed in the rule
is approved by the Director of the Federal Register as of May 31, 2005.
FOR FURTHER INFORMATION CONTACT: Patricia M. Good, Chief, Liaison and
Policy Section, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Telephone (202) 307-7297.
SUPPLEMENTARY INFORMATION:
I. Background
DEA's Legal Authority for These Regulations
DEA enforces the Controlled Substances Act (CSA) (21 U.S.C. 801 et
seq.), as amended. DEA regulations implementing this statute are
published in Title 21 of the Code of Federal Regulations (CFR), Part
1300 to 1399. These regulations are designed to establish a framework
for the legal distribution of controlled substances to deter their
diversion to illegal purposes and to ensure that there is a sufficient
supply of these drugs for legitimate medical purposes.
Requirements for Distributing Schedule I and II Controlled Substances
The CSA prohibits distribution of Schedule I and II controlled
substances except in response to a written order from the purchaser on
a form DEA issues (21 U.S.C. 828(a)). DEA issues Form 222 to
registrants for this purpose, preprinting on each form the registrant's
name, registered location, DEA registration number, schedules, and
business activity. DEA serially numbers the forms and requires
registrants to maintain and account for all forms issued. Executed and
unexecuted Forms 222 must be available for DEA inspection. The CSA
requires that executed Forms 222 be maintained for two years (21 U.S.C.
828(c)).
When ordering a Schedule I or II substance, the purchaser must
provide two copies of the Form 222 to the supplier and retain one copy.
Upon filling the order, the supplier must annotate both copies of the
form with details of the controlled substances distributed, retain one
copy as the official record of the distribution, and send the second
copy of the annotated Form 222 to DEA. Upon receipt of the order, the
purchasers must also annotate their copy, noting the quantity of
controlled substances received and date of receipt.
Regulatory History
Although the paper-based regulatory structure limits diversion, it
does not address or provide for the use of modern computer
technologies. DEA issued more than six million individual order forms
in fiscal year 2003. Because both the purchaser and supplier must
maintain copies of the form for two years, the order system requires
the maintenance of more than 24 million forms. Many, if not most, of
the registrants using Form 222 place all their orders for Schedules
III-V controlled substances electronically. Many suppliers receive
electronic notice from their purchasers of their intention to place
Schedule I and II orders, but the orders cannot be filled until the
supplier receives the DEA-issued Form 222 from the purchaser. The
processing of the Form 222 takes one to three days from the time the
form is completed to the time the order is delivered; electronic orders
can be processed and filled immediately.
DEA Pilot Project
Industry asked DEA to provide an electronic means to satisfy the
legal requirements for order forms. DEA began discussions with the
regulated industry regarding CSOS standards in 1999. On January 11,
2002, DEA published a notice in the Federal Register expressing its
intent to conduct a pilot project to conduct performance verification
testing of public key infrastructure enabled controlled substances
orders. This pilot project was conducted in partnership with two
industry associations--the Health Care Distribution Management
Association and the National Association of Chain Drug Stores. A total
of 22 DEA registrants were listed as initial pilot participants.
Initial pilot objectives were to ascertain the level of compatibility
and usability of CSOS standards for electronic controlled substances
ordering applications and to test industry's ability to deploy these
systems. All technical test objectives were successfully realized in
early phases of the pilot with registrants demonstrating the ability to
retrieve and manage their CSOS digital certificates. Where participants
expressed difficulty or reported undue burden with processes (e.g.,
with initial notarization requirements for enrollment) proposed
technical standards were reviewed and modified, where possible, without
compromising necessary nonrepudiation and security services objectives.
In August 2002, pilot participants began using CSOS certificates in
simulated environments with DEA providing access to a test suite of
CSOS certificates. Pilot participants demonstrated the ability to send,
receive and validate digitally signed controlled substances orders in a
test environment, and also demonstrated the ability to accurately
reject orders, as appropriate. Pilot outcomes allowed DEA to identify
and resolve potential challenges before the controlled substances
ordering system was proposed. DEA continues to provide test resources
to industry through the use of its pilot system, allowing continued
refinement of CSOS applications.
Summary of Proposed Rule
On June 27, 2003, DEA issued a Notice of Proposed Rulemaking (NPRM)
in which DEA proposed revisions to its regulations to allow electronic
orders if those orders were signed using an electronic signature that
met three criteria--authentication, non-repudiation, and record
integrity (68 FR 38558). Because only digital signatures based on
certificates issued by a Certification Authority as part of a public
key infrastructure (PKI) meet all three criteria, DEA proposed
requirements that apply to obtaining and using digital certificates.
[[Page 16903]]
DEA proposed allowing regulated entities who are eligible to order
Schedule I and II controlled substances to issue and process electronic
orders if those orders are signed using a digital certificate issued by
a Certification Authority run by DEA; the approach is called the
Controlled Substance Ordering System or CSOS. Use of electronic orders
is optional; registrants may continue to issue orders on Form 222.
DEA proposed minor organizational revisions to the existing
requirements in Part 1305 to create subparts. Subpart A includes those
requirements that apply to all orders. Subpart B covers the
requirements for handling Form 222 orders. Other than minor editorial
changes to make the regulations easier to read, the existing
requirements for paper orders are unchanged. A new subpart C was
proposed to cover the requirements for issuing and filling electronic
orders. These requirements parallel those for Form 222 orders, but
include some differences based on the different constraints on the two
systems. For example, the regulation specifies the data elements
required on an electronic order; because these elements are part of the
Form 222, they are not specified for paper orders. Orders submitted on
paper must be filled by a single registered location because the
original order form must be maintained at the distribution location in
support of the distribution; electronic orders may be divided and
filled from separate registered locations owned by the same company,
since the order can be retrieved directly in verifiable form at each
distributing location.
In addition to its revision of Part 1305, DEA proposed a new Part
1311 that includes the requirements for obtaining, storing, using, and
renewing digital certificates. Registrants and people granted power of
attorney by registrants to sign orders will be eligible to obtain
digital certificates. A registrant must appoint a CSOS coordinator who
will serve as that registrant's recognized agent regarding issues
pertaining to issuance of, revocation of, and changes to digital
certificates issued under that registrant's DEA registration. These
individuals serve as knowledgeable liaisons between one or more DEA
registered locations and the CSOS Certification Authority (CA). The
coordinators will collect applications, ensure that they include all of
the required information, and send them to the CA. Part 1311 also
specifies the requirements that the digital signature software will
have to meet to ensure that it is capable of creating and validating
digitally signed orders.
Procedures for Obtaining a Digital Certificate
Procedures for enrolling to obtain a digital certificate are
available on the DEA Diversion Control Program Web site, https://
www.deadiversion.usdoj.gov, and on the DEA E-Commerce Web site at
https://www.deaecom.gov. Applicants can download the Diversion PKI CSOS
Enrollment document and the CSOS Subscriber's Manual for guidance on
enrollment procedures. DEA will begin accepting applications to obtain
digital certificates May 31, 2005. Upon receiving a completed
application DEA estimates that it will take the Certification Authority
10 business days to process the application. DEA's Certification
Authority will maintain a support line to assist applicants and
subscribers with issues pertaining to certificate enrollment, issuance,
revocation, and renewal.
PKI and Digital Certificates
A public key infrastructure is comprised of a Certification
Authority, which must verify the identity of applicants before issuing
digital certificates, and public-private key pairs. PKI systems are
based on asymmetric cryptography: the holder of the digital certificate
has a private key, which only the certificate holder can access, and a
public key, which is available to anyone. What one key encrypts, only
the other key can decrypt. It is computationally infeasible for the two
keys to be derived from each other. Only one public key will validate
signatures made using its corresponding private key. Because the
private key is held by only one person, it is that person's
responsibility to ensure that it is not divulged or compromised.
The DEA Certification Authority (CA) will issue digital
certificates, which will serve as an electronic equivalent of the Form
222. DEA must serve as the CA because a digital certificate is the
functional equivalent of a Form 222 that the CSA requires DEA to issue.
In the same manner as DEA pre-prints the registration information on
the paper order forms that are issued to registrants, DEA will enter
the registration information in extensions within the certificates that
are issued to registrants and those granted power of attorney by
registrants.
As DEA explained in the NPRM, the process of digitally signing an
order is technically complicated (the software uses several complex
algorithms to create an encrypted digest of the text), but the user
needs only to activate the key and then enter one or two key strokes to
sign an order or validate it. Existing electronic order systems will
have to be PKI-enabled, which can be done with commercially available
toolkits. DEA has been working with industry to develop systems and
procedures that allow PKI-enabling existing systems to reduce the cost
of implementation.
CSOS Certificates
All of the information currently preprinted on the Form 222 will be
part of the extension data of the CSOS digital certificate, which will
be included with each order that is digitally signed. Attaching the
digital certificate, with the registration information in the extension
data, to an electronic order signed with the digital signature is the
functional equivalent to DEA pre-printing the registrant information on
the paper forms, thus creating an electronic equivalent of the Form
222.
A CSOS certificate will be valid until the DEA registration under
which it is issued expires or until the CSOS CA is notified that the
certificate should be revoked. Certificates will be revoked if the
certificate holder is no longer authorized to sign Schedule I and II
orders for the registrant, if the information on which the certificate
is based changes, or if access to the private key has been compromised
or lost.
II. Discussion of Comments on the NPRM
DEA received 11 comments on its proposed rule. Commenters included
the major trade associations representing pharmacies and distributors
as well as individual companies and one vendor. This section summarizes
the comments and provides DEA's response.
Listed schedules. Several commenters were concerned with proposed
rule language that implied that the digital certificate would include
extension data that indicated the schedules the certificate holder
rather than the registrant was authorized to order. The commenters
stated that it would be an additional burden on suppliers if they had
to verify the eligibility of the signer, as well as the registrant, to
order specific schedules.
DEA has revised the rule language to clarify that only the
registrant's authorized schedules will be included in the extension
data. If a registrant limits an individual's signing authority, it is
incumbent on the registrant to ensure that the individual does not sign
orders for schedules he/she is not authorized to order. The supplier is
not required to verify information on schedules beyond confirming that
the
[[Page 16904]]
registrant is authorized to order the schedules.
Attaching the digital certificate. One commenter expressed concern
about the statements in the preamble that a digital certificate be
attached to each order.
Because the digital certificate serves as the equivalent of the
CSA-mandated form, the certificate, with its extension data, must be
attached to each order. Including the certificate with each order
ensures that, just as with the paper forms, an accurate copy of the DEA
registration information for the customer is with the order. It should
be noted that the requirement that the digital certificate be attached
to the order applies to when the order is transmitted by the purchaser
to the supplier. Once orders have been archived, each order does not
have to have the specific digital certificate attached, as long as the
certificate is associated with the order. Thus, an archive may have one
copy of a specific certificate that is associated with a number of
orders that have been archived, provided that retrieval of an order
includes a copy of the certificate.
FIPS 140-1. Commenters noted that the proposed rule referenced FIPS
140-2, but did not mention FIPS 140-1, causing concern that systems
validated and approved under 140-1 might not be allowed under the new
standard. They were further concerned because the rule did not specify
the security level required. Commenters stated that requiring a
standard beyond security level 1 would cause difficulties for
participants.
FIPS 140-2 grandfathers FIPS 140-1; any system validated and
approved under FIPS 140-1 is considered to be approved and validated
under FIPS 140-2. Therefore, the regulatory provision that
implementations be certified under FIPS 140-2 incorporates, by
reference, any implementations previously certified under FIPS 140-1.
With respect to the security level required, DEA agrees with comments
that Security Level 1 is appropriate and has included it in the final
rule.
Commenters objected to the requirement that the private keys be
stored on a FIPS-approved module. As DEA explained in the NPRM,
government agencies must adopt FIPS requirements for any federal
system, such as CSOS. DEA, therefore, must require that storage of keys
be on FIPS-approved systems. While DEA encourages the use of
smartcards, biometrics, or other secure hardware devices for private
key storage within the CSOS architecture, use of such devices is
voluntary. The regulations only require that the private key be stored
on a FIPS-approved cryptographic module.
Power of Attorney. A number of commenters raised issues related to
the power of attorney (POA) provisions. Several suggested that the
existing requirement that the POA letter be signed by the person who
signed the most recent registration application is impractical for
companies that have national or regional distribution operations. Other
commenters suggested that the application for a digital certificate,
handled through the CSOS coordinator, could replace the POA letter and
process.
The intent of this rulemaking is to establish an electronic means
of satisfying the order form requirements--not to change the existing
order form requirements. DEA did not propose to change the POA
requirement or process, which was established to ensure that all
activities by a registrant with respect to order forms be under the
ultimate control of one responsible individual within the registrant.
Any concerns regarding existing requirements with respect to POA will
have to be considered in a separate action; they are beyond the scope
of this CSOS rulemaking.
With respect to the suggestion that application for a digital
certificate serve as a substitute for granting power of attorney, DEA
wishes to note that the granting of power of attorney is an explicit
legal act of assignment of authority from an authorized individual to
another; accepting the application for a digital certificate as a
substitution would make the assignment implicit, which would not be
acceptable to DEA. Any assignment of the authority to obtain and
execute order forms on behalf of a registrant must be an explicit legal
act.
One commenter noted that the language in Sec. 1305.12(d) that
states that orders must be signed by a person authorized to sign an
application for registration was wrong and should state that orders
must be signed either by a person who is authorized to sign a
registration application or a person granted POA to sign orders. DEA
agrees and has changed the rule.
Tracking number. Several commenters stated that the format of the
unique tracking number that a registrant assigns to an order was
incorrect, that the last two digits of the year should come first. DEA
agrees and has corrected the rule.
Order contents. Commenters suggested several changes to the
requirements for order contents. DEA agrees that the complete address
of the supplier could be provided by either the purchaser or the
supplier and has changed the rule. Similarly, DEA agrees that the order
could include either the National Drug Code (NDC) number or the drug
name. DEA emphasizes that the system used to view the orders must
provide the drug description if the NDC code is used in the order.
Linked records. Commenters objected to the use of the phrase
``electronically linked'' records because they think that links could
be electronic or manual. In technical discussions with DEA, industry
clarified that their concern was that DEA might interpret
``electronically linked'' to require active rather than passive links,
where all order data are linked automatically. Passive links would
allow the data to be stored in separate databases linked by one or more
data elements common to all records.
DEA emphasizes that it is not requiring any specific type of link;
DEA's only concern is that if it requests copies of orders (e.g., for a
particular customer or substance), the registrant must be able to
produce the requested records (i.e., both the electronic orders and the
linked distribution records) upon request in a format that an agent can
read and understand. DEA has revised the rule to clarify that
``readable format'' means that a person, not a computer, can easily
read the documents.
Corrections. Several commenters identified changes needed to
correct regulatory language. In Sec. 1305.22(c)(1), DEA proposed that
suppliers should verify the signature and order by ``having'' software
that complies with Part 1311. The commenter recommended ``using''
instead of ``having.'' DEA agrees and has made the change.
Commenters stated that the proposed language in Sec. 1305.25(b)
and (c) that requires the supplier to provide a reason for not filling
the order was inconsistent with the existing rule. DEA agrees and has
changed the language to clarify that a supplier must notify a purchaser
that an order will not be filled, however, the supplier does not need
to provide a reason for refusing to fill an order.
Commenters asked DEA to make the definition of digital certificate
specific to CSOS. DEA disagrees. The definition is intended to be
general and will cover more than CSOS certificates. In the regulatory
text, however, DEA has added ``CSOS'' before digital certificate
wherever the certificate is limited to the CSOS certificate.
One commenter asked whether ``a registrant's recognized agent'' was
different from a CSOS coordinator. The two are the same; DEA has
revised the
[[Page 16905]]
rule to replace registrant's recognized agent with CSOS coordinator.
Central Ordering. A commenter asked whether the Sec. 1305.22(f)
requirement to ship to the registered location of the purchaser allowed
for shipment to a different registered location if the order was issued
by a central ordering facility. A number of firms issue orders for all
their registered locations from a central location which may not,
itself, be registered. Each order, however, can be for only one
specific registered location and the supplier must ship to that
location. If the registered location identified within the order
deviates from that identified within the digital certificate, the
supplier cannot fill the order; a new order must be requested from the
purchaser.
Commenters also recommended that for central processing of orders
that DEA allow either the central location or the location filling part
of the order to create the record. DEA agrees that either location may
create the record and has revised the rule. DEA's concern is not with
the creation of the record, but with its maintenance. The registrant
that distributes a controlled substance must maintain a full record of
the order and make it available for DEA on request.
One commenter raised the issue of linking a single certificate to
multiple locations. As DEA explained in the NPRM, DEA understands the
concern and has taken steps to reduce the burden for individuals who
hold keys for many locations, but to serve as an equivalent of a Form
222, each digital certificate must be specific to a single registered
location.
Endorsed, lost, and canceled orders. Commenters questioned whether
the proposed rule for endorsing electronic orders could be implemented,
noting that the requirements were confusing and cumbersome. DEA has
reviewed this issue and agrees with the commenters that endorsing
electronic orders in a manner that provides adequate safeguards may be
technically too complicated. Consequently, DEA has decided to not allow
endorsement of electronic orders. Because orders are rarely endorsed
and the almost instantaneous communication of electronic orders and
confirmations mean that a purchaser will learn that the supplier cannot
fill all or part of an order shortly after the order is submitted, DEA
does not expect this to pose any significant problem for registrants.
The purchaser can quickly issue a new electronic order to another
supplier for any items the first supplier cannot fill. Finally, if the
order is originally submitted to a firm that processes orders
centrally, the central processing supplier can fill the order from
multiple locations without endorsement.
Commenters also stated that the meaning of Sec. 1305.26 on lost
orders was confusing and requested that only the purchaser maintain
records of lost orders. DEA agrees and has revised the rule to specify
that a supplier need maintain only those orders that the supplier
fills.
Commenters stated that suppliers should not be required to maintain
records of orders that are canceled. DEA agrees. Suppliers are only
required to maintain records of orders that they fill. Suppliers need
not return the electronic order to the purchaser, however, the supplier
must notify the purchaser of the cancellation of the order. Commenters
also said that purchasers should be able to use any method to notify
the supplier that an order was canceled. DEA disagrees. Notification of
an order cancellation must be written so that the purchaser can
maintain a verifiable record. Written notification includes paper,
facsimile, or electronically transmitted notifications such as e-mail;
notification by telephone is not allowed.
Validity of a signature. Commenters asked whether it was feasible
to determine whether a signature was valid at the time of signing.
Commenters were particularly concerned that, if there was a delay in
processing an order, they should be able to reject an order if the
signature was no longer valid at the time of shipping.
The purpose of the requirement for consistent time systems is to
allow suppliers to determine whether a signature was valid at the time
of signing. If a digital signature was valid on Friday when the order
was signed, but expired on Monday, DEA considers that the order is
valid. Unless DEA or the purchaser has notified a supplier that orders
issued by a specific person should not be filled, an order signed with
a digital certificate that was valid at the time of signing is a valid
order. A registrant may choose not to fill the order for any reason; if
registrants want to require that the signature still be valid at the
time of filling, they may do so. Suppliers have the option of imposing
more stringent standards. As a secondary note, DEA wishes to stress
that once a supplier has validated a signature on an order, it is not
necessary to re-validate the signature prior to actually shipping the
order to the purchaser.
Time period for reporting key compromise or loss of privilege.
Commenters objected to the requirement that they report loss, theft, or
compromise of the key within 24 hours of such loss, theft, or
compromise, and that they report a certificate holder's loss of signing
privilege within six hours. They also stated that they wanted to be
able to report loss of signing privilege in advance (e.g., when they
learn an employee will be leaving the firm on a certain date). They
stated that the 24-hour and 6-hour time frames were unrealistic and
could result in notifications filed outside of business hours.
Registrants may notify the CA in advance of revocations. DEA agrees
that the 24-hour period should be within 24 hours of substantiation of
key compromise, etc., and has changed the rule. On the 6-hour
notification, DEA disagrees with the commenters. DEA believes it is
important that the CA be notified as soon as someone's signing
privileges are revoked. The digital certificate is the equivalent of a
Form 222--a former employee still in possession of their digital
certificate and keys would have all they needed to generate orders that
would be otherwise indistinguishable from legitimate orders. In the
paper world, this concern does not exist since a former employee would
no longer have access to the order forms and, thus, could not engage in
any mischief. DEA notes that the CA will be staffed 24/7 so there is no
need to wait until the next business day. An e-mail to the CA that is
digitally signed by the coordinator or registrant will be sufficient
notification.
Certification Authority. Commenters raised concerns about the DEA
CA being run by a contractor and asked about the safety of information.
DEA emphasizes that although a contractor may be used to carry out the
day-to-day operations of the CA, the contractor will operate under
direct DEA supervision and control. All Federal contractors are subject
to the same legal requirements as government employees in regard to
protection of information. DEA may use information submitted in its
investigations, but the information would not be released for other
purposes.
Reports to DEA. Commenters objected to the requirement that
suppliers file reports on orders with DEA every other business day.
They stated that this frequency of filing would not provide them with
an opportunity to review and correct minor discrepancies. With paper
orders, DEA knows which registrants have executed Form 222, which
provides a control on the system. DEA needs frequent reports on
electronic orders because it has no other means of determining who is
ordering and in what volume. DEA recognizes that some
[[Page 16906]]
of the data may be imprecise due to changes in orders, but DEA needs
frequent submissions of reports to account for all orders generated by
a given purchasing registrant and as a means to identify and account
for all outstanding orders for a given registrant.
Commenters also recommended changes to the information provided in
the daily reports to make the data elements consistent with ARCOS data
elements and to add four elements on the substances ordered. DEA agrees
with the commenters. DEA will specify a format for the report that is
consistent with the ARCOS reports plus the data fields on what was
ordered. DEA notes that ARCOS is preparing to allow electronic filing
of reports; when this occurs, DEA plans to develop a process by which
the summary reports can be accepted as a substitute for ARCOS reporting
for Schedule I and II substances, with the usual ARCOS provisions for
filing corrections.
Adoption of new technologies. Commenters stated that it was unclear
how DEA would evaluate new technologies and recommended that DEA
develop a rapid means for evaluating and approving new technologies.
DEA understands the commenters' concern, but approval of any new
technology would be subject to the Administrative Procedure Act
requirements for public notice and comment prior to adoption. Beyond
the statutory mandates, DEA thinks it is vital that the regulated
community have an opportunity to consider and discuss new methods to
ensure that any new rules can be accommodated by existing systems.
Although the development of this rule took several years, DEA believes
that the time was well spent because discussions that DEA and industry
held made it possible for all parties to identify potential problems
and find solutions prior to publishing a regulation. DEA does not
anticipate that review and recognition of suitable alternative
technologies should take that long.
Audits. Comments expressed concern about the scope of the third-
party audits and DEA audits. They specifically stated that the reports
to DEA should not be included in the third-party audits.
DEA agrees with the commenters that the reports to DEA would not be
part of third-party audits. The independent third-party audit is
intended to ensure that the digital signature system functions properly
for both the supplier and purchaser.
Reverse Distributors. Several commenters asked how the electronic
order system will work for reverse distributors. DEA recognizes that
the ordering system has different characteristics in reverse
distribution and intends to address issues related to those
distributions in a separate rulemaking.
Other Issues. Commenters objected to the mention of biometrics and
smart cards. DEA notes that certificate holders may want to consider
using biometric passwords or smart cards, but DEA is not requiring them
to do so. Keys may be stored on any secure system provided that the
storage module is approved under FIPS 140-2.
Commenters questioned the use of ``system.'' DEA agrees with
commenters that systems for creating and processing digitally signed
orders may be one or more software systems. As noted above, DEA's
concern is the integrity and availability of the records of orders, not
the technologies and software used to create and store the information.
Commenters asked that DEA include a definition or description of
the subscriber agreement. DEA does not believe that it is necessary to
define the subscriber agreement. The DEA CA will provide the agreement,
appropriately titled, to each certificate holder.
Commenters objected to the statement in the NPRM that the practical
implementation of PKI systems is simple. DEA understands and explained
in the NPRM that the technologies involved in PKI systems are complex,
but from the user's standpoint, digital signatures are simple because
so much of the work is actually done by machine. After authenticating
themselves to the system and activating the key, the signer generally
digitally ``signs'' the document with a single key stroke.
One commenter raised issues related to digital certificates for
pharmacists for use in the electronic prescription system. This issue
is beyond the scope of this notice; DEA will address the issue when it
proposes its rule for electronic prescriptions.
A commenter noted that the five-year transition period used in the
economic analysis may be optimistic. DEA recognizes that the electronic
orders may phase in at a different rate; some registrants may continue
to use Forms 222 indefinitely, as the rule allows. The five-year period
was simply used to estimate costs to avoid understating those costs.
One commenter supported the proposed rule, but expressed the hope
that pharmacies would not bear the cost of implementation. DEA notes
that use of electronic orders is voluntary. DEA believes that the
system will provide cost savings to both purchasers and suppliers, but
no registrant is required to adopt electronic orders.
One vendor recommended that DEA adopt an approach more consistent
with the vendor's technology. DEA is not dictating a particular
technology or PKI implementation. Any approved system that meets the
criteria for authentication, non-repudiation, and record integrity may
be used.
Special Note Regarding Certificate Extension Data
Finally, following publication of the proposed rule, DEA modified
the specification for the certificate extensions. Certain registrants
had expressed concerns regarding using the certificates for other
health care purposes because their DEA registration number appeared in
plain text in the certificate, thus making it easily accessible to the
recipient. To address this concern, DEA has modified the certificate
profile to allow that, in lieu of listing the plain text DEA number,
the DEA number extension will contain a hash value generated from the
DEA number and the specific certificate subject distinguished name
serial number using the SHA-1 hashing algorithm. Because the DEA number
will no longer be available in plain text in the certificate, DEA is
modifying the order format requirement in Section 1305.21 to require
that the purchaser include their DEA registration number in the body of
the order. Further, Section 1311.55 is being amended to require that a
supplier must verify that the DEA number listed in the body of the
order is the same as the DEA number associated with the certificate.
The verification is necessary to avoid circumstances where a person who
has been granted POA for multiple registered locations does not
inadvertently sign an order with the wrong certificate/private key.
III. Discussion of the Final Rule
Except for the changes discussed above, DEA is adopting the rule as
proposed. Part 1305 has been reorganized to place requirements that
apply to all Schedule I and II orders in subpart A; these include old
Sec. Sec. 1305.01, 1305.02, 1305.03, 1305.04, which retain their
numbers, old Sec. 1305.07 (power of attorney), which is redesignated
as Sec. 1305.05, old Sec. 1305.08 (persons entitled to fill orders),
which is redesignated as Sec. 1305.06, and old Sec. 1305.16 (special
procedures for filling certain orders), which is redesignated as Sec.
1305.07. The remainder of old Part 1305 is subpart B, which covers the
requirements for obtaining, executing, and filling orders on Form 222.
Subpart B includes old Sec. Sec. 1305.05 and 1305.06 (procedures for
obtaining and executing
[[Page 16907]]
Forms 222), which are redesignated as Sec. Sec. 1305.11 and 1305.12,
and old Sec. Sec. 1305.09-1305.15, which are redesignated as
Sec. Sec. 1305.13-1305.19. These sections include specific references
to orders on Form 222.
Subpart C covers the requirements for electronic orders.
Section 1305.21 specifies that an electronic order must be signed
with a CSOS digital certificate and that the order may include
substances other than Schedule I and II controlled substances. The
section specifies the data fields that must be included in electronic
orders.
Section 1305.22 specifies procedures for filling electronic orders.
Section 1305.23 covers endorsing electronic orders. As discussed
above, endorsement of electronic orders will not be allowed.
Section 1305.24 covers central processing of orders. These
requirements are also different for electronic orders because with
electronic orders, the supplier may have multiple registered locations
fill parts of an order provided that the supplying company owns and
operates all of the locations filling an order.
Sections 1305.25 and 1305.26 specify the requirements for handling
unaccepted and defective electronic orders and lost orders.
Section 1305.27 covers preservation of electronic orders.
Section 1305.28 covers canceling and voiding electronic orders.
Section 1305.29 specifies the requirements for reporting electronic
orders to DEA. Suppliers may submit either a copy of the order and its
linked records or a report in a format DEA specifies. DEA intends that
the report will be identical to the ARCOS report in format with four
additional data elements: the NDC number, quantity, unit, and strength
ordered.
New Part 1311 covers the requirements for digital certificates.
Subpart A includes the scope, definitions, standards for electronic
orders, and incorporations by reference. Subpart B covers the
requirements for obtaining and using CSOS digital certificates.
Section 1311.10 specifies who is eligible to obtain a CSOS
certificate; Sec. 1311.15 covers the limitation of certificates to the
schedules authorized for the DEA registration under which the
certificate is issued. The revised section states that the registrant
is responsible for ensuring that any person whose signing authority the
registrant limits abides by those limits.
Section 1311.20 specifies the requirements for CSOS coordinators.
Section 1311.25 specifies the requirements for obtaining a CSOS
certificate.
Section 1311.30 provides the requirements for using and storing a
digital certificate.
Section 1311.35 specifies the number of certificates needed.
Section 1311.40 specifies when a new certificate must be obtained.
Section 1311.45 specifies requirements for registrants that grant
power of attorney authority.
Section 1311.50 specifies requirements for recipients handling
electronic orders prior to filling them.
Section 1311.55 specifies software requirements for handling
electronic orders.
Section 1311.60 specifies recordkeeping requirements.
Part 1305.--Distribution Table
------------------------------------------------------------------------
Old section New section
------------------------------------------------------------------------
1305.01--Scope of part 1305............ 1305.01--Scope of part 1305.
1305.02--Definitions................... 1305.02--Definitions.
1305.03--Distributions requiring order 1305.03--Distributions
forms. requiring order forms.
1305.04--Persons entitled to obtain and 1305.04--Persons entitled to
execute order forms. obtain and execute order
forms.
1305.05--Procedure for obtaining order 1305.11--Procedure for
forms. obtaining DEA Forms 222.
1305.06--Procedure for executing order 1305.12--Procedure for
forms. executing DEA Forms 222.
1305.07--Power of attorney............. 1305.05--Power of attorney.
1305.08--Persons entitled to fill order 1305.06--Persons entitled to
forms. fill DEA Forms 222.
1305.09--Procedure for filling order 1305.13--Procedure for filling
forms. DEA Forms 222.
1305.10--Procedure for endorsing order 1305.14--Procedure for
forms. endorsing DEA Forms 222.
1305.11--Unaccepted and defective order 1305.15--Unaccepted and
forms. defective DEA Forms 222.
1305.12--Lost and stolen order forms... 1305.16--Lost and stolen DEA
Forms 222.
1305.13--Preservation of order forms... 1305.17--Preservation of DEA
Forms 222.
1305.14--Return of unused order forms.. 1305.18--Return of unused DEA
Forms 222.
1305.15--Cancellation and voiding of 1305.19--Cancellation and
order forms. voiding of DEA Forms 222.
1305.16--Special procedure for filling 1305.07--Special procedure for
certain order forms. filling certain DEA Forms 222.
------------------------------------------------------------------------
Incorporation by Reference
The following standards are incorporated by reference:
FIPS 140-2, Security Requirements for Cryptographic
Modules.
FIPS 180-2, Secure Hash Standard.
FIPS 186-2, Digital Signature Standard.
These standards are available from the National Institute of
Standards and Technology, Computer Security Division, Information
Technology Laboratory, National Institute of Standards and Technology,
100 Bureau Drive, Gaithersburg, MD 20899-8930 and are available at
https://csrc.nist.gov/.
V. Required Analyses
Executive Order 12866
This regulation has been drafted and reviewed in accordance with
Executive Order 12866, ``Regulatory Planning and Review'', Section
1(b), Principles of Regulation. It has been determined that this is a
``significant regulatory action'' under Executive Order 12866, Section
3(f), Regulatory Planning and Review, and accordingly this rule has
been reviewed by the Office of Management and Budget.
DEA has conducted a cost-benefit analysis of the rule, which the
Office of Management and Budget has reviewed. The Economic Impact
Analysis for the proposed rule was posted on the Diversion Control
Program Web site. That analysis has been updated to account for the
number of orders expected in 2004 (6,561,000), the first year of
implementation, and to adjust registrant estimates based on data from
DEA's ARCOS reporting system. DEA estimates that about 98,000
registrants order Schedule I and II controlled substances and will
apply for about 145,000 digital certificates. Over ten years, DEA
estimates that electronic orders will reduce the annualized cost of
Schedule I and II orders by $284 million; the annualized costs of
digital
[[Page 16908]]
certificates are estimated to be $20 million. The annualized net
benefit of the rule, therefore, is $264 million.
As discussed in the NPRM, DEA developed estimates of the time
required for each step in the process of issuing and processing an
order and used weighted wage rates based on the number of orders
registrant groups are estimated to issue. DEA estimates that issuing
and processing a Form 222 order costs purchasers about $26 and
suppliers about $13. In contrast, issuing and processing a digitally
signed order will cost about $2.60 for purchasers and $3.00 for
suppliers. (These costs do not include the cost of obtaining a digital
certificate or installing software, most of which are one-time costs.)
The costs for a single registrant vary depending on the number of
orders issued and filled. DEA estimates that annual costs for Form 222
orders range from $26 for a registrant who issues a single order to
more than $184,000 for distributors who both issue and fill orders. The
annual costs for electronic orders range from $2.60 to about $40,000.
The initial registrant costs of obtaining a digital certificate range
from $156 to about $600, varying with the number of applicants a
registrant has.
Table 1 presents the total annual hours and costs for the Form 222
system for 2004 orders. Tables 2-4 present the total annual hours and
costs for obtaining digital certificates, issuing electronic orders,
and developing and installing software, if these activities occurred in
a single year.
Table 1.--Total Annual Hours and Costs for the Form 222 System
[2004 orders]
----------------------------------------------------------------------------------------------------------------
Hours Labor Capital O&M Total
----------------------------------------------------------------------------------------------------------------
Purchaser:
Complete and send order..... 1,640,250 $139,323,000 .............. $7,355,000 $146,677,000
Requisition order........... 3,124 265,000 .............. 23,000 288,000
Annotate order.............. 328,050 27,865,000 .............. .............. 27,865,000
File orders................. 109,350 3,087,000 $129,700 2,668,000 4,472,000
Supplier:
Enter order................. 1,640,250 58,770,000 .............. .............. 58,770,000
Annotate order.............. 328,050 21,212,000 .............. .............. 21,212,000
Compile and send to DEA..... 90,936 3,258,000 .............. 174,000 3,433,000
File orders................. 109,350 3,918,000 129,700 2,668,000 5,303,000
-----------------
Total................. 4,249,360 257,698,000 259,000 12,887,000 270,844,000
----------------------------------------------------------------------------------------------------------------
Table 2.--Total Hours and Costs for Digital Certificates
----------------------------------------------------------------------------------------------------------------
Hours Labor O&M Total
----------------------------------------------------------------------------------------------------------------
Purchaser:
Complete application........................ 58,950 $5,007,000 .............. $5,007,000
Complete application--coordinator........... 78,755 6,689,000 $638,000 7,328,000
Generate keys............................... 12,116 1,029,000 .............. 1,029,000
Learn to use signature...................... 20,778 1,765,000 .............. 1,765,000
Renewal--one year........................... 1,234 105,000 .............. 105,000
Renewal--3 year-annual...................... 3,627 308,000 .............. 308,000
Supplier:
Complete application........................ 3,311 214,000 .............. 214,000
Complete application--coordinator........... 345 22,000 2,790 25,000
Generate keys............................... 406 26,000 .............. 26,000
Learn to use signature...................... 2,032 131,000 .............. 131,000
Renewal..................................... 406 26,000 .............. 26,000
-----------------
Total................................... 181,960 15,324,000 641,000 15,965,000
----------------------------------------------------------------------------------------------------------------
Table 3.--Total Hours and Costs for Electronic Orders
----------------------------------------------------------------------------------------------------------------
Hours Activities Total cost
----------------------------------------------------------------------------------------------------------------
Purchaser:
Sign orders................................................. 36,450 6,561,000 $3,096,000
Edit and archive............................................ 164,025 6,561,000 13,932,000
Supplier:
Validate orders............................................. 27,338 6,561,000 1,768,000
Collect and send to DEA..................................... 5,473 109,460 354,000
Edit and archive............................................ 273,375 6,561,000 17,676,000
-----------------
Total................................................... 506,661 .............. 36,826,000
----------------------------------------------------------------------------------------------------------------
[[Page 16909]]
Table 4.--Total Hours and Costs for the Electronic Order Software
----------------------------------------------------------------------------------------------------------------
Hours Labor O&M Total
----------------------------------------------------------------------------------------------------------------
Purchaser:
Install--chains............................. 8,680 $666,000 .............. $666,000
Install software--other..................... 314,408 13,010,000 .............. 13,010,000
Install--practitioner....................... 43,940 1,818,000 .............. 1,818,000
Supplier:
Install software............................ 280 11,600 .............. 11,600
Software Developer:
Development................................. 103,600 9,700,000 .............. 9,700,000
Maintenance................................. 89,000 3,683,000 .............. 3,683,000
Upgrades.................................... 17,800 1,367,000 .............. 1,367,000
Audit....................................... 2,314 96,000 $593,000 689,000
-----------------
Total................................... 580,022 30,352,000 593,000 30,945,000
----------------------------------------------------------------------------------------------------------------
To estimate costs over the first ten years, DEA assumed that
implementation would be phased in over the first five years (i.e., it
would be five years before all registrants were using the electronic
order system). Based on discussions with industry, the phase-in was
estimated to occur at 20 percent in the first year, 40 percent in the
second, 20 percent in the third, and 10 percent each in the fourth and
fifth years. DEA made the conservative estimate that orders would phase
in at the same rate as digital certificates. Because a few distributors
and large chain drug stores supply and order a large proportion of the
drugs, it is likely that orders will phase in more quickly than digital
certificates will. A faster phase-in will increase the net benefits; a
slower rate would lower the benefits.
DEA also assumed that the number of orders would increase seven
percent annually. The seven percent increase is based on the average
annual increase in orders over the last seven years. The total cost of
both systems was estimated using a seven percent and a three percent
discount rate. Table 5 presents the ten-year total cost of orders under
the Form 222 system, the electronic system, and the combined systems as
the electronic system is phased in over the first five years as well as
the annualized cost of the three systems over ten years. Table 6
presents the costs of digital certificates and software needed to
create digitally signed orders.
Table 5.--Total Cost of Orders Over Ten Years
[Present value]
----------------------------------------------------------------------------------------------------------------
Combined phase-
Paper system Electronic system in
----------------------------------------------------------------------------------------------------------------
Total (7%)............................................. $2,699,913,000 $298,086,000 $704,112,000
Annualized (7%)........................................ 384,407,000 42,441,000 100,250,000
Total (3%)............................................. 3,223,440,000 363,653,000 781,438,000
Annualized (3%)........................................ 377,886,000 42,631,000 91,608,000
----------------------------------------------------------------------------------------------------------------
Table 6.--Total Costs of Digital Certificates and Software Over 10 Years
[Present value]
------------------------------------------------------------------------
New costs
------------------------------------------------------------------------
Total (7%).............................................. $149,308,000
Annualized (7%)......................................... 21,258,000
Total (3%).............................................. 172,093,000
Annualized (3%)......................................... 20,275,000
------------------------------------------------------------------------
In addition to the cost savings, electronic orders will also
provide a number of other benefits that cannot be quantified.
Purchasers will be able to create and send single unified controlled
substance orders to their suppliers. With Forms 222, purchasers must
create the separate Form 222 for the Schedule I and II controlled
substances and complete other orders for all other controlled substance
purchases from a particular supplier. If a purchaser needs more than 10
Schedule I or II substances, multiple Forms 222 must be completed
because the form is limited to ten items. With the electronic orders,
they will be able to submit a single order covering all controlled
substance and other prescription drugs being purchased from the
supplier. The combined orders should reduce the orders that need to be
logged, tracked, and handled by both purchasers and suppliers.
Electronic orders should also bring faster receipt of controlled
substances. Under the present system, the purchaser has the choice of
sending the order by overnight service at considerable cost, mailing it
and waiting several days, or sending the order back with the delivery
truck, which may not be returning directly to the distributor. In most
cases, the purchaser is likely to have to wait at least two days and
possibly four or five days when the order is mailed or is shipped back
by truck. If the distributor that receives the order cannot fill it,
the distributor may endorse it to another distributor and ship it on to
another distribution point, further delaying the final shipment.
Electronic orders will be received almost instantly and can be shipped
the same day. This speed may allow purchasers to order only when they
need an item and limit the quantity of controlled substances that they
stock. Limiting the quantity of Schedule I and II controlled substances
in stock reduces the possibility of diversion and the cost of security.
With the Form 222, if a supplier cannot fill all of an order, the
supplier may endorse the entire order over to another supplier. The
order cannot be divided and filled in part by one supplier and in part
by a second, even if both suppliers belong to the same company. Because
each location holds a separate registration, a distributor with
multiple locations must maintain stocks of all Schedule I and II
controlled substances at each location to be able to fill orders for
these substances from that location. Some distributors have created
centralized systems where all orders are
[[Page 16910]]
processed through the central distribution office, which then transmits
parts of the orders to the warehouses that hold specific items. The
Form 222 system cannot take advantage of this arrangement because the
paper must accompany the order. With electronic orders, DEA will allow
a distributor with a central distribution system to divide an order and
ship parts of the order from different distribution points. New orders
will not need to be generated because the central computer system can
track each item in the order and ensure that it is shipped to the
appropriate registrant only once. DEA and the supplier will have the
records necessary to maintain the closed system of control while
allowing the supplier to take advantage of its own system of
distribution.
A copy of the Economic Impact Analysis of the Electronic Orders
Rule is available on the Diversion Control Program's Web site.
Regulatory Flexibility Act
The Regulatory Flexibility Act (5 U.S.C. 601-612) requires Federal
agencies to determine whether regulations have a significant economic
impact on a substantial number of small entities or have a
disproportionate effect on small entities. DEA, as part of its economic
analysis, considered the costs of the existing system and the
electronic system on small entities. The annualized costs of the Form
222 system for the smallest entities (Narcotic Treatment Programs with
less than $100,000 in revenues), are 1.66 percent of annual revenues;
for these registrants, the annual costs of the electronic orders are
about 0.24 percent of annual revenues. For most small entities affected
by the rule, the cost of the electronic system will be less than 0.1
percent of revenues or sales. Consequently, the Deputy Administrator
hereby certifies that this rulemaking has been drafted in accordance
with the Regulatory Flexibility Act (5 U.S.C. 605(b)), has reviewed
this regulation, and by approving it certifies that this regulation
will not have a significant economic impact on a substantial number of
small entities.
A copy of the small business analysis for this proposed rule, which
is section 7 of the economic analysis, can be obtained from the
Diversion Control Program web site or by contacting the Liaison and
Policy Section, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Telephone (202) 307-7297.
Small Business Regulatory Enforcement Fairness Act of 1996
This rule has been determined to be a major rule as defined by
Section 804 of the Small Business Regulatory Enforcement Fairness Act
of 1996. This rule will result in an annual effect on the economy of
$100,000,000 or more, but will not impose a major increase in costs or
prices; or significant adverse effects on competition, employment,
investment, productivity, innovation, or on the ability of United
States-based companies to compete with foreign-based companies in
domestic and export markets. In fact, this rule will result in a
significant reduction in the cost of ordering Schedule I and II
controlled substances.
Paperwork Reduction Act
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) submitted the following information collection requests to the
Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. Under the
Paperwork Reduction Act, DEA is required to estimate the burden hours
and other costs of any requirement for recordkeeping and reporting over
a three-year period. Therefore, DEA proposed the revision of an
existing collection of information U.S. Official Order Forms for
Schedules I and II Controlled Substances (Accountable Forms), Order
Form Requisition, (OMB Control # 1117-0010), and the creation of a new
collection of information Reporting and Recordkeeping for Digital
Certificates under the Paperwork Reduction Act of 1995. This process is
conducted in accordance with 5 CFR 1320.11. The Information Collection
Request was submitted to the Office of Management and Budget for review
under section 307 of the Paperwork Reduction Act.
Overview of U.S. Official Order Forms for Schedules I and II Controlled
Substances (Accountable Forms), Order Form Requisition Information
Collection
(1) Type of information collection: Revision of existing
collection.
(2) The title of the form/collection: U.S. Official Order Forms for
Schedule I and II Controlled Substances (Accountable Forms), Order Form
Requisition.
(3) The agency form number, if any, and the applicable component of
the Department sponsoring the collection:
Form No.: DEA Form 222, U.S. Official Order Forms for Schedule I
and II Controlled Substances (Accountable Forms)
DEA Form 222a: Order Form Requisition
Applicable component of the Department sponsoring the collection:
Office of Diversion Control, Drug Enforcement Administration, U.S.
Department of Justice
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: Non-profit, state and local governments.
Abstract: DEA-222 is used to transfer or purchase Schedule I and II
controlled substances and data are needed to provide an audit of
transfer and purchase. DEA-222a Requisition Form is used to obtain the
DEA-222 Order Form. Persons may also digitally sign and transmit orders
for controlled substances electronically, using a digital certificate.
Orders for Schedule I and II controlled substances are archived and
transmitted to DEA; both the supplier and purchaser must retain records
for two years.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond/reply: DEA
estim